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Abstract 
Quitting smoking itself is a stressor; it is likely that other stressors occur concurrently 
and deplete self-regulatory resources.  Failure to cope leads to smoking relapse.  
Exercise has been shown to attenuate cravings and withdrawal symptoms in 
previous research and has yet to be examined following concurrent stressors.  This 
study examined the effect of an acute bout of moderate intensity exercise on 
psychological withdrawal symptoms (PWS), cravings and ad lib smoking after 
concurrent stressors (i.e., temporary abstinence and depletion).  Twenty-five 
smokers were randomized into exercise or passive conditions.  Results showed 
PWS were significantly exacerbated after temporary abstinence and again after 
depletion for both conditions.  A significant group x time interaction effect was found 
for cravings favouring exercise.  Exercise had no effect on ad lib smoking.  This is 
the first study to show craving reductions after exercise following concurrent 
stressors and represents a more ecologically valid lab-based scenario.  
 
Keywords: smoking, temporary abstinence, self-regulation, acute exercise, 
concurrent stressors 
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Chapter One: Literature Review 
Introduction 
Smoking is the most important cause of premature death in Canada 
(Makromaski-Illing & Kaiserman, 1999).  Currently, 19.9% of those aged 12 and over 
smoke cigarettes daily or occasionally, resulting in approximately 5.8 million current 
smokers (Statistics Canada, 2011).  Even though smoking prevalence has declined 
over the past decade, this pattern has now slowed (Reid, Hammond, Burkhalter, 
Rynard & Ahmed, 2013).  Cigarette smoking is the cause of many chronic diseases 
such as lung and bladder cancers and is a risk factor for other diseases such as 
coronary heart disease and ischemic stroke (U.S. Department of Health and Human 
Services (USDHHS), 2004; 2010).  Even low levels of exposure to cigarettes 
smoking (e.g., one puff of a cigarette or second-hand exposure) can lead to rapid 
and sharp declines in endothelial function and inflammation.  These are risk factors 
for cardiovascular events and thrombosis (USDHHS, 2010).  Yet individuals 
continue to smoke despite these detrimental health consequences.  This is primarily 
due to smokers becoming dependent on cigarettes. 
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Smoking Addiction 
 In 2011, nearly half (45.4%) of smokers and recent quitters had quit in the 
past year (Statistics Canada, 2011).  Of those who had quit, only 10.7% had stayed 
quit for one year (Reid et al., 2013).  This quit rate is higher for those who seek 
pharmacological treatment (22%; Gonzales et al., 2006) and lower for those who try 
to quit on their own (4 – 7%; American Cancer Society, 2013).  This modest smoking 
cessation success rate is a clear indicator that smoking is a powerful addiction, 
which is very difficult to quit for long periods of time.  There are many factors that 
sustain smoking behaviour; it is likely that these factors also affect prolonged 
smoking abstinence.   
 Nicotine is the addictive agent in cigarettes.  In addition to being highly 
addictive, nicotine is also a habit-forming substance (Pomerleau, Collins, Shiffman & 
Pomerleau, 1993).  While there has yet to be consensus on criteria for nicotine 
addiction, USDHHS, Diagnosis and Statistical Manual of Mental Disorder, 4th edition 
(DSM – IV; American Psychological Association (APA), 2000) and International 
Classification of Diseases, 10th revision (World Health Organization, 1992) have 
agreed on some basic criteria (Table 1; USDHHS, 1988).  Thus, outlining that 
smoking is a harmful and addictive habit.  Furthermore, nicotine and smoking 
behaviour have various biological, psychobehavioural and environmental factors 
associated with it, which will be discussed in further detail in this section. 
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Table 1 
Primary and additional criteria for nicotine addiction (USDHHS, 1988). 
Primary Criteria Additional Criteria 
• Highly controlled or compulsive 
use 
• Psychoactive effects 
• Drug-reinforced behaviour 
• Addictive behaviour often involves 
o Stereotypic pattern of use 
o Use despite harmful effects 
o Relapse following abstinence 
o Recurrent drug cravings 
• Dependence-producing drugs often 
produce 
o Tolerance 
o Physical dependence 
o Pleasant (euphoriant) effects 
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Biological factors.  Nicotine is an agonist for nicotine acetylcholine receptors 
and has effects on the central and peripheral nervous systems (Holladay, Dart & 
Lynch, 1997).  Nicotine binds to these receptors, which leads to dopamine release 
(McGehee and Role, 1996).  This gives the smoker strong pleasant and rewarding 
feelings.  Moreover, the receptors located in the ventral tegmental area of the brain 
(located near the brainstem and part of the reward circuit) are activated and have 
been linked to the reinforcement aspect of nicotine (USDHHS, 2010).  These factors 
make smoking cessation very difficult to achieve, as the reward aspect of smoking is 
complex and challenging to reshape or break.     
 Genetics play an important role in the uniqueness of smoking behaviour. 
Variations, or polymorphisms, of the CYP2A6 gene contribute to different patterns of 
smoking behaviour and cessation rates.  Those who are quicker to metabolize 
nicotine show an increase in smoking activity and decrease in smoking cessation 
activity compared to slower nicotine metabolizers (Munafo, Clark, Johnstone, 
Murphy & Walton, 2004).  These polymorphisms can contribute to smoking 
cessation success rates, as quicker metabolizers are less likely to be successful 
(Munafo et al., 2004).  In addition to biological effects, nicotine is a psychoactive 
substance, which alters normal behaviour (APA, 2000).  
 Psychobehavioural factors.  As individuals continue to smoke, they become 
more tolerant of nicotine (Kalant, LeBlanc & Gibbins, 1971).  Chronic tolerance 
decreases a smoker’s responsiveness to nicotine, leading to an increase in number 
of cigarettes smoked (Kalant et al., 1971).  A smoker is dependent on nicotine when 
they abstain from smoking and there is a significant increase in cravings and 
withdrawal symptoms (USDHHS, 2010).  Cigarette cravings vary based on 
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dependence.  Similarly, withdrawal symptoms also vary and include: affective 
disturbances (i.e., irritability, anger, anxiety and a depressed mood) and behavioural 
symptoms (i.e., restlessness, sleep disturbance and increased appetite) (APA, 
2000).  Moreover, cognitive disturbances are also common, including difficulty 
concentrating and perceived difficulty coping with daily life events (Hughes, 2007).  
Withdrawal symptoms have been tightly linked to pattern of use, time course, 
intensity and relationship with relapse (USDHHS, 2010). 
 Due to its role in the mesolimbic pathway, or reward system of the brain, 
nicotine is a reinforcing drug.  A stimulus is defined as reinforcing if the behaviour or 
response to obtain the stimulus is increased.  Drugs are reinforcing if self-
administration of the drug is more than that of an inert substance (Everitt & Robbins, 
2005).  There are behavioural grounds for reinforcing smoking, some include 
changing negative affect (e.g., reducing restlessness, sadness or anxiety), 
suppressing appetite to maintain weight, increasing coping abilities in stressful 
situations and enhancing concentration during cognitively demanding tasks (Perkins, 
1993; Heishman, Taylor & Henningfield, 1994; Kassel, Stroud & Paronius, 2004).  
Reinforcement of self-administration of nicotine (i.e., smoking) is clearly modulated 
by positive and negative factors that lead to learning and increased smoking 
behaviour (Tiffany, Conklin, Shiffman & Clayton, 2004).  There are many cues that 
can spark this learning cycle, such as those found in a smoker’s environment. 
 Environmental factors.  Cues from the environment can have a large impact 
on smoking behaviour.  Clinical studies use a cue-elicited smoking paradigm, 
whereby participants are exposed to various smoking-related (i.e., lit cigarette sitting 
in an ash tray) or environmental stimuli (i.e., cognitive interference via Stroop task) 
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(Carter & Tiffany, 1999; Munafo, Mogg, Roberts, Bradley & Murphy, 2003).  Cues 
elicit physiological and psychobehavioural responses, such as increased heart rate, 
galvanic skin response and increased desire to smoke (Niaura, Abrams, Monti & 
Pedraza, 1989; Carter & Tiffany, 1999; Waters, Shiffman, Sayette, Paty, Gwaltney & 
Balabanis, 2004).  According to Conklin & Tiffany (2002), smoking cessation 
treatments that can dampen a smoker’s response (i.e., cravings) to environmental 
stimuli and related cues may increase the likelihood of prolonged smoking cessation.  
 In summary, smoking addiction/dependency is complex and involves the 
interplay of biological, psychobehavioral and environment factors. This interplay 
makes it easy to see how quitting smoking can be very difficult.  In the next section, 
stress during a quit attempt and stress due to the environment and cue-related 
stimuli will be discussed with respect to effective treatments for reducing cravings 
and withdrawal symptoms. 
 
Stress During a Quit Attempt 
 In a stressful situation (i.e., during a quit attempt) an individual must 
constantly monitor the stimulus and override the natural tendency to let one’s 
attention wander (Matthews, Scheier, Bunson & Carducci, 1989).  In order to 
successfully cope with a stressor, individuals must override or stop thoughts, urges 
and emotions in addition to regulating attention (Lazarus & Folkman, 1983; 
Pennebaker, 1988; Wegner & Pennebaker, 1993; Eisenber, Fabes & Guthrie, 1997).  
This change in behaviour leads to depletion of self-regulatory resources (Muraven & 
Baumeister, 2000).  This cognitive breakdown may lead to an increase in the 
number of cigarettes smoked and likelihood of relapse (Carter & Tiffany, 1999; 
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Chassin, Presson, Sherman & Kim, 2002).  Moreover, failure to cope with cigarette 
cravings and psychological withdrawal symptoms is associated with high relapse 
rates and accounts for the terrible quit smoking success rates (West, Hajek & 
Belcher, 1989; Killen & Formann, 1997; Piasecki, Naiura, Shadel, Fiore & Baker, 
2000; Taylor & Katomeri, 2007).  An examination of current treatments to alleviate 
cravings and withdrawal symptoms during a quit attempt is discussed below. 
 Pharmacological treatments.  Oral (e.g., gum, spray, lozenge) nicotine 
replacement therapy (NRT) has been shown to have an acute effect on cigarette 
cravings (Ferguson & Shiffman, 2009).  For instance, Niaura and colleagues (2005) 
showed that rapid-release nicotine gum showed a more rapid and meaningful relief 
of nicotine cravings compared to nicotine polacrilex gum.  In addition, experimental 
research has shown transdermal NRT (patch) to reduce cravings and withdrawal 
symptoms best when combined with another therapy (Stead et al., 2012).  Moreover, 
pharmacological aides such as varenacline (Champix®) and sustained-release 
bupropion (Zyban®) have been shown to be efficacious in clinical trials (Scharf & 
Shiffman, 2004; Jorenby et al., 2006).  However, in cue-elicited situations, the 
effectiveness of these aides is inconsistent (Wilson, Sayette, Delgado & Fiez, 2005; 
Weinstein et al., 2009). 
 Non-pharmacological treatments.  While it is acknowledged that there are 
various forms of non-pharmacological treatments (e.g., cognitive behavioural 
therapy and counselling from health professionals), this section will review literature 
on exercise, as it is the main treatment used in the present study.  A single bout of 
light-to-moderate intensity exercise has been shown to significantly reduce cravings 
in temporarily abstinent smokers (Daniel, Cropley & Fife-Schaw, 2007; Everson, 
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Daly & Ussher, 2008; Janse Van Rensburg and Taylor 2008; Faulkner, Arbour-
Nicitopoulos & Hsin, 2010; Elibero, Janse Van Rensburg & Drobes, 2011; Harper, 
2011; Janse Van Rensburg, Taylor, Hodgson & Benattayallah, 2012).  Two recent 
meta-analyses (Haasova et al., 2012; Roberts, Maddison, Simpson, Bullen, & 
Prapavessis, 2012) provide further empirical evidence for acute exercise having 
positive effect on cigarette cravings and withdrawal symptoms during abstinence.  It 
has been shown that exercise is more than a distraction from cravings and 
withdrawal symptoms, as the benefits of exercise last after the bout of exercise is 
over (Daniel et al., 2006; Ussher, West, Doshi, & Sampuran, 2006).  In addition, 
treatment expectations are unrelated to reductions in cravings and withdrawal 
following an acute bout of exercise (Daniel et al., 2007; Harper, Fitzgeorge, Tritter, & 
Prapavessis, 2013). 
 In order to further support acute exercise for managing cravings and 
withdrawal symptoms, it is crucial to examine cue-elicited smoking research to 
determine the value of exercise.  Before this literature is reviewed, some background 
on stress due to environment and cue related smoking stimuli and on self-regulation 
is warranted. 
 
Stress Due to Environment and Cue-Related Smoking Stimuli 
 As highlighted in the previous section, smoking is a patterned, habitual 
behaviour and a smoker, who wishes to quit, must exert self-regulation to resist 
smoking urges in addition to withdrawal symptoms such as negative affect, irritability 
and nausea (Tiffany, 1990; Brown, 1998; Carter & Tiffany, 1999).  Coping with a quit 
attempt together with other environmental and cue related stressors is likely to vastly 
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deplete self-regulatory strength (Muraven & Baumeister, 2000).  These situations 
may involve smoking stimuli, social pressures, negative emotional states and/or 
intense smoking urges (Brodbeck, Bachmann & Znoj, 2012).  It is suggested that as 
negative affect increases in response to abstinence, smoking cues and other 
stressors cognitive pathways become biased and promote increased smoking 
behaviour (Shiffman & Waters, 2004).  For instance, non-abstaining smokers smoke 
more cigarettes and experience increased urges to smoke when they have 
experienced more negative life events and perceive higher levels of stress (Todd, 
2004).  Also, a strong predictor of relapse (i.e., one-time event of smoking 
behaviour) is an inability to cope with stressful or high-risk situations, particularly 
those where individuals might reach for a cigarette (Chassin, Presson, Sherman, & 
Kim, 2002).  In order to appreciate the effect of self-regulation during smoking 
cessation, it is imperative to examine the current body of literature.  
 Self-regulation.  To begin, self-regulation is exertion of control over self by 
the self; more specifically it is when a person attempts to alter their normal way of 
thinking, feeling or behaving (Muraven & Baumeister, 2000).  Self-regulation 
involves effort in inhibiting urges, behaviours, desires or emotions.  The limited 
strength model of self-regulation (strength model) suggests that self-regulatory 
strength is needed to execute self-function (Baumeister, 1998).  The model also has 
several key assumptions.  First, self-regulatory strength is limited, such that a person 
has a finite capacity for self-regulation.  Second, all self-regulatory behaviours draw 
from the same resource pool.  Third, self-regulatory success or failure depends on 
an individual’s amount of self-control strength.  If strength is depleted, it may lead to 
a breakdown in self-regulatory behaviour; however, this decrease is not permanent.  
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Tasks that require more self-regulation are more affected by depletion than those 
that require less self-control.  Finally, strength is used up in the process of self-
regulation.  Similar to other limited resource models such as attention, the strength 
model predicts that attempting to regulate multiple behaviours simultaneously, an 
inability to self-regulate, may lead to decreased overall self-regulation.  The strength 
model has implications for health research, in particular, smoking cessation as it 
provides an applicable framework to develop and test hypotheses.     
Compared to other self-regulation behaviours, such as dieting and alcohol 
consumption, smoking cessation has received little attention in terms of application 
of the strength model, as outlined in a review by Hagger, Wood, Stiff and 
Chatzisarantis (2009).  The first study by O’Connell, Schwartz and Shiffman (2008) 
examined the effect of duration and frequency of resisted temptations to smoke on 
urges from two data sets using ecological momentary assessment.  The authors 
predicted that self-regulatory resources would be depleted and result in an increased 
likelihood of relapse in smokers.  Contrary to their predictions, increased frequency 
of resisted temptations actually decreased likelihood of relapse.  Increased relapse 
duration had no effect.  It is possible that the frequency of resisted urges may have 
increased smokers’ ability to resist urges and thereby increased self-regulatory 
strength through training.  While this study took place in a naturalistic setting, 
O’Connell et al. (2008) suggested that the strength model might not be appropriate 
in “real world” settings.  It is also important to note that the authors did not measure 
trait self-regulation, which may have had a moderating effect on intensity of urges 
and quitting (Hagger et al., 2009).   
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Similarly, the strength model and smoking cessation have also been studied 
in a laboratory setting.  Shmeuli and Prochaska (2009) examined the effect of self-
regulation (cognitive) depletion on the likelihood of smoking.  Participants were 
asked to either resist tempting sweets (depletion condition) or raw vegetables 
(control condition).  Participants were given a 10-minute recess where their smoking 
behaviour was discretely observed; this was also biologically verified with breath 
carbon monoxide readings.  Those who were randomized to depletion condition 
were more likely to smoke during the recess (53.2%) than those in control condition 
(34.0%).  The authors suggest that this has implications for self-regulation strength 
as a factor for resisting the urge to smoke and further supports the notion that 
individuals who are attempting to quit smoking should delay dieting behaviours 
(Fiore et al., 2008).  
Extending this research, Shmeuli and Prochaska (2012) looked into 
replenishing self-control strength through positive affect induction.  Smokers were 
depleted in the same manner as the aforementioned study.  Then, either positive or 
neutral affect was elicited through a writing or video condition, after which smoking 
behaviour was observed during a 10-minute recess.  Those randomized to depletion 
and had a positive affect induction via video clips were least likely to smoke (10.5%) 
compared to those who were depleted, but in neutral video or writing conditions 
(65.5% and 85%, respectively).  Interestingly, writing exercises were associated with 
smoking during recess regardless of whether they were positive or neutral.  The 
authors suspect that participants may have written about tobacco-related activities, 
which may have led to smoking during recess.  Limitations of this study include that 
self-control was manipulated, but not directly measured and potentially confounding 
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variables (e.g., arousal, distraction, etc.) were not addressed in this study.  Also, 
smokers in this group reported a 4.1 (SD = 2.5) on the Fagerstrom Test for Cigarette 
Dependence indicating that they have low dependence on cigarettes and this may 
have further confounded results (Heatherton, Kozlowski, Frecker & Fagerstrom, 
1991).  
Limitations.  While these studies provide a good foundation for examining 
self-regulation in smokers, there are a few limitations.  The depletion tasks used are 
not applicable in a real world setting.  For instance, dieting while abstinent may only 
apply to a sub-population of those who wish to quit smoking.  Further, a depleting 
task should represent a more ecologically valid scenario so that it may represent any 
host of stressors, for instance those experienced in daily life.  Another limitation is 
that smoking behaviour was generally modeled, or was observational.  Using a 
quantifiable method, such as those employed in acute smoking study paradigms 
may afford a clearer picture of the effect of cognitive depletion on smoking 
behaviour.  Finally, participants were in relatively calm states, which is not usually 
the case for an individual during a quit attempt.  Thus, further examination of how 
self-regulation influences smoking behaviour during environmental related stress 
(e.g., resisting temptations) is required.  In the next section, studies that have 
examined whether treatments like exercise attenuate increases in cue-elicited 
cravings during abstinence will be reviewed. 
 
Cue-elicited Craving Research   
 Cue-reactivity research, or cue-elicited research is originally derived from 
classical conditioning framework (Tiffany, 1995a).  In this paradigm, addicts are 
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exposed to cues related to their addiction (e.g., drug paraphernalia or drug-use 
situations) and psychological and/or physiological responses are measured.  Cues 
can be presented in a variety of ways such as pictures, audio clips or in vivo.  
Generally, responses are measured through self-report using a measure of craving 
or desire for the drug.  Other measures include heart rate, galvanic skin response 
and sweat gland activation (Carter & Tiffany, 1999).  A meta-analysis conducted by 
Carter and Tiffany (1999) suggests that the cue-elicited research paradigm is useful 
for basic addiction research and robust for psychological responses.  The authors 
also suggest that more insight is needed to determine the factors around cue-elicited 
responses.  
Experimental studies have shown that nicotine replacement therapy (NRT) 
and naltrexone, an opioid antagonist; attenuate increases in cue-elicited cravings 
during smoking abstinence.  Participants who received a 50mg dose of naltrexone 
and NRT had no increase in urge to smoke or negative affect compared to a placebo 
group (Hutchinson et al., 1999).  Conversely, participants using the patch alone have 
produced mixed results.  For instance, high dose patches (35mg) attenuate overall 
cravings, some withdrawal symptoms (i.e., concentration and negative affect), but 
have no effect on cue-provoked cravings (Shiffman et al., 2003; Waters et al., 2004).  
Similarly, lower dose patches (21mg) attenuate effects of abstinence, but have 
limited effect on cue-elicited cravings and urges (Tiffany, Cox & Elash, 2000; 
Morissette et al., 2005).   
 Using a non-pharmacological approach, Taylor and Katomeri (2007) showed 
that a single bout of exercise could moderate cue-elicited cravings and withdrawal 
symptoms during a temporary quit period.  Following a 2-hour abstinence period, 
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participants were randomized to either a 15-minute brisk walk or passive condition.  
Both groups completed a set of tasks (i.e., stressors) following their respective 
treatment conditions.  Exercise attenuated strength of desire to smoke, tension, poor 
concentration and stress in response to a lit cigarette, but had minimal effects on 
cravings and withdrawal symptoms in response to other stressors (i.e., Stoop task 
and speech task).  Moreover, participants who exercised lit up a cigarette 57 
minutes later than passive controls after leaving the laboratory.  
 While the study conducted by Taylor and Katomeri (2007) advances 
knowledge, it nevertheless has some limitations.  First, a 2-hour abstinence period 
may not have been long enough to elicit intense cravings and withdrawal symptoms, 
which are more reflective of a true quit attempt.  Next, the stressors were presented 
after the treatment condition, and although this was not the authors’ main objective, 
a more ecological scenario would be to present the stressors immediately after the 
temporary abstinence.  It is unknown whether a single bout of exercise is beneficial 
when a smoker is experiencing a temporary abstinence period (stress condition 1) 
followed by exposure to a cognitive depletion task and/or cue-elicited smoking 
stimuli (stress condition 2).  This situation mirrors a real life situation where 
individuals often have to simultaneously deal with both types of stressors.  The 
combined effects of both stressors may not be the same as those felt when an 
individual engages in a temporary quit attempt, only.  In other words, the severity of 
the withdrawal symptoms, specifically the psychological symptoms, will likely be 
higher for those experiencing concurrent stressors.  This in turn, makes it more 
challenging for treatments like exercise to work in reducing cravings. 
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Purpose and hypotheses  
 The purpose of this study is to examine the effect of a single bout of exercise 
on cigarette cravings, psychological withdrawal symptoms and ad libitum smoking 
following concurrent stressors (temporary smoking abstinence period and cognitive 
depletion/cue-elicited smoking stimuli).  
 Hypothesis 1 (manipulation check—concurrent stressors).  All 
participants will experience higher psychological withdrawal symptoms following 
temporary abstinence and then again following cognitive depletion/cue-elicited 
smoking stimuli.  
 Hypothesis 2 (primary outcome—cravings).  Compared to passive 
controls, those who perform an acute bout of moderate intensity exercise will 
experience lower cravings following temporary abstinence and cognitive 
depletion/cue-elicited smoking stimuli. 
 Hypothesis 3 (secondary outcome—ad libitum smoking).  Compared to 
passive controls, those who perform an acute bout of moderate intensity exercise 
will take a longer time to light up their first cigarette following temporary abstinence 
and cognitive depletion/cue-elicited smoking stimuli. 
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Chapter Two: The Current Study 
 
Methods 
Participants 
 Healthy male and female smokers (N = 36) were recruited using 
advertisements in local newspapers and online classifieds at Western University, 
Fanshawe College and the London community (Appendix A).  Inclusion criteria 
included: (a) aged 18 – 65 years; (b) smoked an average of 10 cigarettes or more 
per day for at least two years; and (c) no contraindications to physical activity.  
Exclusion criteria included: (a) for females, were pregnant or intending on becoming 
pregnant before completion of the study and (b) an inability to temporarily abstain 
from smoking for a minimum of 12 hours.  Twenty-five participants (Mage = 37.4, SD 
= 14.8) who satisfied all criteria completed this study and were randomized into one 
of two conditions: moderate intensity exercise (experimental arm) or passive sitting 
(control arm).  Participants included 14 females and 11 males.  
Design 
 This research study used a stratified (age and sex), two-group randomized 
controlled trial design.  A computer-generated numbers table accomplished 
randomization for age (18-30 years, 31-50 years, 51-65 years) and sex (male, 
female).  Participants, but not researchers, were blinded to group allocation and 
were unapprised to the existence of a second condition.  Refer to Figure 1 for 
participant study flow diagram. 
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Manipulation (Fidelity) Check for Concurrent Stressors 
 The Shiffman-Jarvik withdrawal scale is a 15-item questionnaire that 
assesses tobacco withdrawal symptoms in smokers attempting to quit smoking 
(Shiffman & Jarvik, 1976).  Items are measured on a 7-point Likert scale anchored at 
1 definitely do not feel and 7 definitely feel.  The items are divided into subscales 
based on factor analysis: cravings (five items), psychological symptoms (five items), 
physical symptoms (three items), sedation (one item) and appetite (one item).  For 
the purpose of this study, only the psychological subscale (see Appendix B) was 
administered to validate that participants’ scores for psychological distress increased 
from baseline to post-abstinence (stress condition 1) and then again from post-
abstinence to post-cognitive depletion/ cue-elicited smoking stimuli (stress condition 
2).  In the current study, this scale demonstrated acceptable reliability based on 
Cronbach’s alpha (at baseline α = .73; post-abstinence α = .82; post-cognitive 
depletion/ cue-elicited smoking stimuli α = .80; 2-minutes post-treatment α = .76).   
 
Primary Outcome Measures 
Cigarette cravings.  Cigarette cravings were measured using strength of 
desire to smoke (West, Hajek & Belcher, 1989).  This scale was measured with a 
single item ‘How strong is your desire to smoke right now?’ scored on a 7-point 
Likert scale from 1 not at all to 4 somewhat and 7 extremely.   
 
Secondary Outcome Measures 
 Ad libitum smoking was calculated as the difference in time from leaving the 
laboratory after post-abstinence assessments (Visit 2) to the time of their first 
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cigarette; this method is consistent with previous research in acute smoking (Taylor 
& Katomeri, 2007).  Participants either emailed the study’s purpose-built email 
address with the time and date of their first cigarette, or called and left a message on 
a secure phone line.  Researchers then calculated the difference between the self-
reported times and expressed this variable in minutes.  
 
Other Measures 
Demographic characteristics.  Demographic information, including: age, 
gender, smoking status (i.e., number of cigarettes per day) and smoking history (i.e., 
number of years smoking regularly) were collected.  Height (m) and weight (kg) were 
recorded and Body Mass Index (BMI; kg/m2) was calculated.  
Physical activity readiness questionnaire.  This seven-item questionnaire 
was used to determine if an individual required medical clearance from a physician 
before engaging in physical activity (CSEP).  Participants responded yes or no to 
items; if a participant responded yes to one or more items then they were excluded 
from the study.  An example of an item is, “Has your doctor ever said that you have 
a heart condition and that you should only do physical activity recommended by a 
doctor?”  
Physical activity.  The Seven Day Physical Activity Recall Questionnaire 
(7DR, Blair, 1985) was used to measure current levels of physical activity.  This 
measure was used to screen individuals at baseline (Visit 1) to ensure that they 
were not already exceeding current physical activity guidelines of 150 minutes of 
moderate to vigorous physical activity per week (CSEP).  This questionnaire 
prompts individuals to remember information about type, duration and intensity of 
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physical activity over the previous seven days.  The 7DR has been used extensively 
in exercise and health research (Daniel, Cropley, Ussher & West, 2004).  
 Smoking dependency.  Perceived dependency of cigarettes was measured 
with the Fagerstrom Test for Cigarette Dependency (FTCD; Heatherton, Koxlowski, 
Frecker & Fagerstrom, 1991).  The FTCD is scored out of 10 points total where a 
score of zero to two indicates a very low dependence; a score of three to four is a 
low addiction; a score of five is a medium addiction; a score of six to seven is high 
addiction and a score of eight to ten is a considered a very high addiction.  The 
FTCD has shown high internal consistency and adequate retest reliability 
(Pomerleau, Carton, Lutzke & Flessland, 1994).  In this study, Cronbach’s alpha was 
slightly below acceptable levels (α = .66); however, inter-item correlation was 
adequate at .22 (Briggs & Cheek, 1986). 
 Readiness to quit smoking. Smoking ladder questionnaire determines the 
readiness of a participant to quit smoking.  It is based on stages of change theory 
and separates smokers based on their readiness to quit (Prochaska & DiClemente, 
1983).  The categories are pre-contemplation (one and two on the ladder); 
contemplation (three and four); preparation (five and six); maintenance (seven and 
eight) and action (nine and ten).  Participants are asked to only select one statement 
that best represents their thoughts as a smoker (Biener & Abrams, 1991).   
 Self-control.  This 13-item measure (Tangney, Baumeister & Boone, 2004) 
assesses individual differences in self-control in various situations.  Items are 
measured on a 5-point Likert scale, 1 not at all and 5 very much.  An example of an 
item is, “I am good at resisting temptation.”  This scale has shown good internal 
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consistency and retest reliability (Tangney et al., 2004).  In the current study, 
Cronbach’s alpha was acceptable (α = .75). 
 Coping self-efficacy.  A general coping measure, Coping Self-Efficacy 
Scale, was used to assess perceived self-efficacy for coping with challenges 
(Chesney, Neilands, Chambers, Taylor & Folkman, 2006).  For the purpose of this 
study, only the emotion and thoughts subscales were used.  This nine-item subscale 
prompts participants to think about their ability to perform behaviours important for 
adaptive coping.  The 11-point scale is anchored by 0 cannot do at all and 10 
certainly can do.  An example of an item is, “When things aren't going well for you, or 
when you're having problems, how confident or certain are you that you can do the 
following: Make unpleasant thoughts go away.”  This measure has shown strong 
internal consistency and test-retest reliability (Chesney et al., 2006).  In the current 
study, Cronbach’s alpha was good (α = .82). 
 
Intervention 
 Moderate intensity exercise.  Participants randomized into this condition 
completed a single, 15-minute bout of moderate intensity exercise.  Moderate 
intensity was defined as 45-68% of heart rate reserve (HRR; Karvonen, Kentala, & 
Mustala, 1957).  HRR was calculated using the formula: maximum heart rate 
(HRmax; 220 – age) – resting heart rate (HRrest) (CSEP).  Resting heart rate (RHR) 
was taken at baseline (Visit 1).  Additionally, resting heart rate can drop by about 8.5 
beats per minute after a temporary abstinence period (Perkins, Epstein, Stiller, 
Marks, & Jacob, 1989).  Resting heart rate was taken before abstinence because it 
is an indicator of normal heart rate; however, if a participant indicated that they had 
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just smoked a cigarette before Visit 1 then a default resting heart rate of 75 beats 
per minute was used in place of RHR.  Rationale for this decision is that smoking a 
cigarette would have elevated their RHR above their normal range.  For moderate 
intensity exercise, the calculation for 45% HRR was: [(HRmax – HRrest) X .45] + 
HRrest.  The calculation for 68% HRR was: [(HRmax – HRrest) X .68] + HRrest 
(CSEP).  Heart rate was monitored using a Polar RS100 heart rate monitor. 
 The exercise condition consisted of a 2-minute warm up, followed by 10 
minutes of walking at a rate, which allowed participants to reach 45% to 68% of their 
HRR and a 3-minute cool down on a treadmill (Woodway, Waukesha, WI).  
Researchers controlled the incline and speed of the treadmill, but participants 
indicated if the speed and incline were appropriate for their current level of fitness.   
Passive sitting.  Participants randomized to this condition were asked to sit 
in a quiet room for 15 minutes.  They were not discouraged from reading.   
 
Procedure 
Conduct of this trial followed principles outlined in the Declaration of Helsinki 
(World Medical Association, 2008) and the World Health Organization Good Clinical 
Research Practice (World Health Organization, 2002).  Conduct and reporting 
followed CONSORT principles (www.consort-statement.org).  Ethical approval was 
obtained from Western University’s Health Sciences Research Ethics Board 
(#103019; Appendix A) and participation was voluntary.  All participants read the 
Letter of Information (Appendix A), had his/her questions answered and signed a 
Consent Form (Appendix A) prior to participation in this study. 
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Participants were initially screened for eligibility criteria by telephone or e-
mail.  After initial screening, eligible and interested participants were asked to come 
in for a baseline assessment (Visit 1) to further confirm initial screening.  Screening 
questions included smoking status (i.e., number of cigarettes smoked per day), 
smoking history (i.e., number of years as a regular smoker), current physical health 
and PAR-Q.  If a participant answered, “yes” to any question on the PAR-Q they 
were ineligible to participate.  This study involved completing two assessments 
baseline and post-abstinence (Visit 1 and Visit 2) at the Exercise and Health 
Psychology Laboratory (EHPL; www.ehpl.uwo.ca) at Western University in London, 
Ontario, Canada (see Figure 1).  
Baseline assessments (Visit 1) included verification of smoking status using 
the piCO+TM Smokerlyzer® carbon monoxide (CO) monitor (Bedfont Scientific Ltd., 
Kent, England).  A breath CO reading of greater than 10 parts per million (ppm) was 
the threshold of inclusion as used in previous research (Daniel et al., 2007).  CO 
monitors were calibrated on a daily basis to ensure accurate readings.  Resting 
heart rate was recorded for all participants.   After, participants completed a 
demographic information sheet.  Participants then completed the following: (1) 7DR 
(Blair, 1985); (2) FTCD (Heatherton et al., 1991); (3) strength of desire to smoke 
(West et al., 1989); (4) Shiffman-Jarvik withdrawal scale – psychological subscale 
(Shiffman & Jarvik, 1976); (5) smoking ladder (Beiner & Abrams, 1991); (6) Coping 
Self-Efficacy Scale (Chesney et al., 2006) and (7) Brief Self-Control Efficacy 
Questionnaire (Tangey et al., 2004).  Questionnaires can be found in Appendix B.  A 
schedule of measures can be found in Table 2.  Visit 1 took about one hour to 
complete. 
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Post-abstinence assessment (Visit 2) was scheduled 4-7 days after baseline 
(Visit 1).  Prior to the second assessment, participants were required to abstain from 
smoking for 18 hours (stress condition 1).  In addition, participants were also asked 
to abstain from common forms of substance dependency (i.e., caffeine and alcohol) 
to ensure clean or unenhanced psychological responses to questionnaires and 
Stroop task at the second visit.  This is consistent with other temporary abstinence 
studies (Taylor & Katomeri, 2007).  Temporary abstinence was verified using expired 
CO; a reading of less than 10ppm validated temporary abstinence.  Next, 
participants completed a questionnaire packet containing strength of desire to 
smoke (West et al., 1989) and psychological withdrawal subscale (Shiffman & 
Jarvik, 1976) (Table 2).   
Regardless of randomization, participants underwent depletion via a modified, 
augmented computerized Stroop task and cue-elicited smoking stimuli (stress 
condition 2).  The Stroop task is a direct measure of depletion that incongruently 
matches words and colours, whereby participants are required to say aloud the 
colour of the printed ink and not the word (Williams et al., 1996).  For example, blue 
could be presented in green ink and participant would be required to say green. 
However, when participants came across words in red ink they were required to 
override the first rule and say the actual word and not red.  As an indirect measure of 
depletion, researchers asked participants to place a cigarette of their preferred brand 
on the desk in plain sight (cue-elicited smoking stimulus) before completing the 
Stroop task.  They were informed that for every error made, a dollar would be 
subtracted from their total compensation (augmentation).  Then, participants 
performed this task for 5 minutes and error rate and progress (i.e., number of 
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prompts completed) was recorded.  After depletion, participants completed a 
manipulation check.  This was to ensure that the task did in fact deplete the 
participant rather than energize them, or have no effect. 
During treatment conditions (either moderate intensity exercise or passive 
sitting), participants’ cigarette cravings were assessed at 5-minute intervals.  Two 
minutes after participants completed their treatment conditions they completed a 
final, post-treatment questionnaire packet (see Table 2).   
Upon questionnaire completion, participants were asked to report the time of 
their first cigarette after leaving the lab.  Participants were given an envelope that 
contained the debriefing letter (Appendix A) and their full compensation.  A reminder 
slip with their participant number and laboratory and study information was attached 
to the envelope (Appendix A).  Researchers reiterated the importance of calling or e-
mailing prior to opening the envelope.  Also, a reminder sticker was placed across 
the seal to further encourage participant compliancy.  Participants reported their 
participant number and time of first cigarette to either a purpose-made e-mail 
account, or left a voicemail on a secure line at the EHPL.  Researchers contacted 
participants if they did not respond within three hours.   Visit 2 took about 1 hour to 
complete. 
 
Sample Size Calculation 
Manipulation check (concurrent stressors).  Previous research has shown 
Shiffman-Jarvik withdrawal symptoms psychological subscale scores of 2.55 at 
baseline increases to 3.72 (standard deviations not reported by authors) after a 13-
16 hour period of temporary abstinence (Canamar & London, 2012).  Moreover, no 
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previous research exists to inform power analysis for psychological symptoms after 
temporary abstinence and depletion (concurrent stressors).  It is anticipated that the 
additional stressor of depletion will likely elevate psychological symptoms from 3.72 
to 4.2 (SD = 1.0).  Hence, in order to be adequately powered (power = .82) to detect 
this difference, a sample size of 25 smokers is needed with the alpha set at 0.05 
(SamplePower 3, IBM-SPSS). 
Post-treatment.  It is anticipated that post-treatment differences in strength of 
desire after temporary abstinence and depletion will be larger [treatment mean = 
3.67 (SD = 1.96) vs. control mean = 6.3 (SD = 1.0)] than differences in strength of 
desire after temporary abstinence only [treatment mean = 2.81 (SD = 1.96) vs. 
control mean = 5.48 (SD = 1.18); Taylor & Katomeri, 2007].  Hence, a sample size of 
10 for each arm is needed to be powered at 0.92 with an alpha of 0.05 to detect 
these differences (SamplePower 3, IBM-SPSS).   
 
Statistical Analyses 
Group equivalency.  One-way ANOVAs were used to determine group 
equivalency at baseline for (a) key demographic, smoking status and psychological 
variables (i.e., age, gender, cigarettes smoked per day, smoking history, physical 
activity levels, self-control and coping self-efficacy); and (b) the primary and 
secondary outcome variables (i.e., strength of desire and psychological symptoms).   
Manipulation check (exercise).  A paired t-test was used to determine if 
those randomized to moderate intensity exercise had increased their heart rates 
from baseline to post-exercise. 
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Manipulation check (concurrent stressors).  Repeated measures analysis 
of variance (ANOVA) and follow-up post-hoc paired t-tests were used to determine if 
psychological symptoms increased from baseline to post-abstinence (stress 
condition 1) and then again from post-abstinence to post-depletion (stress condition 
2) (hypothesis 1).  
Primary and secondary outcome analyses.  For the primary outcome, a 
group (moderate intensity exercise or passive control) by time (baseline, post-
abstinence, post-depletion, 5 minutes, 10 minutes, 15 minutes into treatment and 
immediately post-treatment) repeated measures ANOVA was used to determine an 
interaction effect for cravings (hypothesis 2).  Planned post-hoc t-tests followed a 
significant interaction.  For the secondary outcome, an independent t-test was 
conducted for ad lib smoking comparing means between treatment groups 
(hypothesis 3).  Finally, bivariate correlation was used to establish linear relations 
between key variables of interest (age, years smoked, cigarettes smoked per day, 
baseline expired CO, FTCD, smoking ladder, brief self-control and coping self 
efficacy scores), post-depletion psychological withdrawal, post-treatment cravings 
and ad lib smoking scores. 
The level of significance was accepted at p < .05 for all tests (Tabachnick & 
Fidell, 1996).  For t-tests, all p-values are two-tailed.  Effect sizes (η2) accompany all 
reported findings.  In accordance with Cohen (1988), 0.01 is a small effect size, 0.06 
is a moderate effect size, and 0.14 is a large effect size.  Data were analyzed using 
IBM SPSS Statistics (Version 21).
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Table 2  
Schedule of measures. 
Variable 
 
Baseline 
Post-
abstinence 
Post- 
depletion 
(manipulation 
check) 
During 
Treatment 
– 5 min 
During 
Treatment 
– 10 min 
During 
Treatment 
– 15 min 
Post-
treatment 
PAR-Q x       
Expired CO x x      
Demographics 
and smoking 
history 
x       
Physical 
activity recall 
x       
FTCD  x       
Psychological 
withdrawal 
symptoms 
x x x     
Smoking 
ladder x       
Strength of 
desire to 
smoke 
x x x x x x x 
Self-control  x       
Coping self-
efficacy  
x       
Ad libitum 
smoking 
      x 
Note. FTCD = Fagerstrom Test for Cigarette Dependency.  Treatment conditions are 
either moderate intensity exercise or passive sitting.  
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Results 
 
Treatment of Data 
 Missing data.  Data from participants who did not complete an outcome 
measure during testing (baseline and post-abstinence assessments) were omitted 
from that measure.  This occurred three times at baseline (Visit 1) for 7-day Physical 
Activity Recall Questionnaire, only.  No data were missing at post-abstinence 
assessment (Visit 2).  Participants who missed Visit 2 were omitted from the data 
set.   
 Outliers.  Outliers were identified using a boxplot; if a datum point was more 
than 1.5 box-lengths from the edge of the box it was considered an outlier.  Outliers 
and extreme outliers were removed from the final data set.  At Visit 2, fourteen 
outliers were discovered.  Three outliers for hours abstained from smoking (2 
experimental and 1 control), six for ad lib smoking (2 experimental, 4 control), two for 
modified Stroop task errors (1 experimental and 1 control) and three for days in 
between assessments (Visit 1 and Visit 2).  No outliers were found at Visit 1.  
 Assumptions of statistical techniques.  Assessment of normality was 
accomplished through skewness and kurtosis values and checking histogram 
shapes for distribution.  Finally, Kolmogorov-Smirnov statistic was used to further 
assess normality.  Assumptions of normality were not violated. 
 Repeated measures analysis of variance (ANOVAs) and one-way ANOVAs 
were assessed for assumptions of homogeneity of variances with Levene’s test for 
equality of variances.  Assumptions were violated for hours abstained from smoking 
(p = .04).  Repeated measures were also checked for homogeneity of inter-
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correlations using Box’s M statistic.  Assumptions were not violated.   
 Repeated measures ANOVAs were assessed for sphericity using Mauchly’s 
Test of Sphericity statistic.  Upon inspection, assumptions were violated for cravings 
and thus, test within-subjects Greenhouse-Geisser statistics are reported. 
Finally, bivariate correlations were checked for assumptions of linearity and 
homoscedasticity by examining the distribution of data points on a scatterplot. 
Assumptions for homoscedasticity were not violated.   
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Figure 1. Flow diagram of participants moving through the study. 
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Group Equivalency at Baseline 
 Baseline characteristics and one-way ANOVAs for moderate intensity 
exercise vs. passive control groups are shown in Table 3.  There were no significant 
differences between groups for baseline characteristics or strength of desire to 
smoke (cravings) and psychological withdrawal symptoms.  There also were no 
significant differences between groups on any of the demographic, smoking status 
or psychological constructs (i.e., self-control and coping self-efficacy).  Hence, there 
was no need to use any of these variables as potential covariates for the main 
repeated measures ANOVA analysis for cravings. 
    
Manipulation Check  
 Exercise.  A paired t-test showed that there was significant increase in heart 
rate for those who exercised at a moderate intensity from baseline to post-exercise, t 
(11) = -7.28, p < .0001, η2 = .84.  
Concurrent stressors (psychological withdrawal symptoms).  Repeated 
measures ANOVA for psychological withdrawal symptoms showed a significant time 
(baseline to post-abstinence to post-depletion) effect, F (2, 23) = 24.3, p < .0001, η2 
= .50.  Post-hoc paired t-tests showed an increase in psychological symptoms from 
baseline to post-abstinence (stress condition 1; Mdifference = -1.23, SD = 1.46), t (24) = 
-4.23, p < .0001, η2 = .43 and from post-abstinence to post-depletion (stress 
condition 2; Mdifference = -.576, SD = 1.08), t (24) = -2.65, p = .01, η2 = .23.  The 
means and standard deviations are presented in Table 4. 
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Main Analyses 
 Cravings.  For strength of desire to smoke, repeated measures ANOVAs 
revealed a significant group (moderate intensity exercise and passive control) by 
time (baseline, post-abstinence, post-depletion, 5-, 10- and 15-minutes into 
treatment and immediately post-treatment) interaction effect, F (6, 18) = 13.4, p < 
.0001, η2 = .82, for strength of desire (see Table 5 and Figure 2).  Post-hoc t-tests 
showed that the exercise group reported significantly lower craving scores at all post 
concurrent stressor time points compared to their passive control counterparts (see 
Figure 2).  
 Ad lib smoking.  Independent t-test revealed no significant difference for ad 
lib smoking for moderate intensity exercise (M = 12.7, SD = 9.52) and passive 
control (M = 14.1, SD = 12.6), t (17) = -.262, p = .80, η2= .003.    
Relationships among the variables.  There was no significant correlation 
between strength of desire to smoke (cravings) measured post-treatment and ad lib 
smoking (see Table 6).  However, when groups were separated, there was a non-
significant, medium correlation for those who exercised at a moderate intensity (r = -
.463, p = .178) compared to a weak, non-significant correlation for passive controls 
(r = -.147, p = .71) between ad lib smoking and strength of desire to smoke.  No 
significant correlations were found between ad lib smoking and demographic 
variables, smoking status, psychological constructs and post-depletion psychological 
withdrawal symptoms (Table 6).  
In relation to other main variables, psychological withdrawal symptoms 
measured post-depletion were positively and significantly correlated with cigarettes 
smoked per day (Table 6).  Moreover, psychological withdrawal symptoms were not 
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significantly correlated with cravings measured post-treatment.  Cravings were not 
related to self-control or coping self-efficacy (SE).  Similarly, psychological 
withdrawal symptoms were not related to self-control or coping SE (Table 6).  
With respect to the relationship between demographic variables, smoking 
status, psychological constructs, post-depletion psychological withdrawal symptoms 
and post-treatment cravings, significant and positive correlations were found 
between years smoked and the following: cigarettes smoked per day, age and self-
control.  There were significant, positive correlations for cigarettes smoked per day 
and both expired CO score (baseline) and psychological withdrawal symptoms.  
Negative, significant correlations were revealed for FTCD and cigarettes smoked per 
day.  Expired CO and FTCD scores were positively correlated.  Finally, self-control 
and coping SE scores were significantly correlated (Table 6).  
While non-significant, there was a medium, positive correlation for years 
smoked and coping, in addition to a medium, negative correlation for years smoked 
and cravings.  Self-control and coping SE both displayed medium, positive, non-
significant correlations with age as well.  Cravings and coping SE scores showed a 
medium, negative correlation that was also not significant.   
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Table 3  
Mean and standard deviations for baseline (Visit 1) characteristics. 
Characteristics 
Experimental  
(n = 12) 
Control  
(n = 13) 
F η2 p 
Demographics 
Age (years) 35.7 (14.9) 39.1 (15.2) .320 .01 .57 
Female gender, number 
(percent) 
7 (58.3) 7 (53.8) .047 .002 .83 
BMI (kg/m2) 27.6 (6.49) 24.2 (4.83) 2.36 .09 .14 
Moderate/ vigorous 
intensity activity in the 
past week (hours) 
2.71 (1.65) 2.31 (1.57) .717 .01 .58 
Resting heart rate 
(bpm) 
87.0 (13.9) 83.5 (8.98) .556 .02 .46 
Smoking Status 
Years smoked 17.8 (13.3) 21.2 (14.7) .366 .02 .55 
Cigarettes per day 13.0 (5.95) 15.2 (6.08) .796 .03 .38 
FTCD 3.58 (2.07) 4.08 (2.66) .265 .01 .61 
Expired CO (ppm) 17.0 (7.04) 22.2 (9.67) 2.35 .09 .14 
Smoking ladder 5.66 (1.07) 6.11 (1.53) .709 .03 .41 
Strength of desire  3.75 (1.49) 2.85 (1.86) 1.78 .07 .20 
Psychological 
withdrawal symptoms  2.96 (.893) 2.69 (1.13) .449 .02 .51 
Length of smoking 
abstinence (hours) 
18.1 (.370) 17.8 (1.19) .569 .03 .46 
Days between visits 6.40 (1.83) 6.92 (1.44) .546 .03 .47 
Self-Control 2.98 (.352) 2.97 (.741) .001 .0001 .98 
Coping Self-Efficacy 59.0 (13.4) 59.8 (15.6) .017 .0007 .90 
Note. FTCD = Fagerstrom Test for Cigarette Dependence; CO = carbon monoxide. 
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Table 4  
Means and standard deviations (SD) for psychological withdrawal symptoms at three 
time points (manipulation check). 
Time N Mean SD 
Baseline 25 2.82 1.01 
Post-abstinence 25 4.05 1.34 
Post depletion 25 4.63 1.28 
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Table 5  
Mean and standard deviations (SD) for strength of desire to smoke at all data 
collection time points.  
Time Experimental (n = 12) Control (n = 13) 
Baseline 3.75 (1.49) 2.85 (1.86) 
Post-abstinence 5.08 (1.50) 5.38 (1.61) 
Post-depletion 5.58 (1.73) 5.31 (1.75) 
During treatment – 5 minutes 2.83 (1.85) 5.23 (1.79) 
During treatment – 10 minutes 2.92 (1.93) 5.23 (1.69) 
During treatment – 15 minutes 3.00 (2.05) 5.38 (1.61) 
Immediately post-treatment 3.50 (2.15) 5.31 (1.55) 
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Figure 2. The effect of exercise on strength of desire to smoke compared to passive 
control (mean and standard error).  Time points are baseline (1); post-abstinence 
(2); post-depletion (3); during treatment – 5 minutes (4); during treatment – 10 
minutes (5); end of treatment – 15 minutes (6) and immediately post-treatment (7).  
Asterisks indicate significant differences between groups at specific time points (p 
< .05). 
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Table 6  
Correlations between ad lib smoking and key demographic variables and smoking 
status, post-depletion psychological withdrawal symptoms and post-treatment 
strength of desire to smoke (cravings). 
Variable 1 2 3 4 5 6 7 8 9 10 11 
1. Ad lib — -.040 .021 .214 .055 -.01 -.273 -.274 -.242 .083 -.062 
2. Age — — .956* .504 .297 .314 .045 .292 -.273 .338 .357 
3. Years 
Smoked — — — .438* .280 .258 .060 .292 -.388 .397* .344 
4. CPD — — — — .444* -.773* .030 .415* .139 -.050 -.117 
5. CO — — — — — 631* .281 .244 .207 .251 .097 
6.FTCD — — — — — — .048 .318 .301 .052 .098 
7. SL — — — — — — — -.003 .022 .158 .105 
8. PWS — — — — — — — — .132 .095 -.194 
9. SoD  — — — — — — — — — -.238 -.334 
10. SC — — — — — — — — — — .457* 
11. Coping 
SE 
— — — — — — — — — — — 
Note. CPD = cigarettes smoked per day, CO = carbon monoxide, FTCD = 
Fagerstrom Test for Cigarette Dependence, SL = smoking ladder, PWS = 
psychological withdrawal symptoms, SC = self-control, SE = self-efficacy, SoD = 
strength of desire to smoke (cravings).  Asterisk indicates significant relationship (p < 
.05). 
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Chapter Three: Discussion 
 
The present study aimed to examine the acute effect of a single bout of 
exercise on strength of desire to smoke (cravings) and ad lib smoking following 
concurrent stressors.  Results showed that following concurrent stressors (i.e., 
temporary abstinence and depletion), significant reductions in cravings were seen 
for those in the moderate intensity exercise condition, but not for those in the 
passive control condition; however the treatment had no effect on ad lib smoking.  
Beyond these general findings, the following specific issues warrant commentary. 
 
Effect of Concurrent Stressors on Psychological Withdrawal Symptoms 
 Concurrent stressors represent a more realistic setting for a smoker when 
they attempt to quit.  Sources of stress often unfold unexpectedly, leaving individuals 
in a heightened state of arousal.  For individuals engaging in a quit attempt, added 
stressors can exacerbate an already challenging process and increase the chances 
of relapse (Carter & Tiffany, 1999).  Intervening at this point of heightened stress is 
therefore important.   
In the present study, psychological withdrawal symptoms were selected as 
the manipulation check as they were salient to both stressor conditions (i.e., 
temporary abstinence and depletion) and likely to change in response to each 
condition.  The manipulation check supported a significant increase in psychological 
withdrawal symptoms following temporary abstinence (stress condition 1) and again 
following depletion (stress condition 2). 
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 Self-regulation is exertion of control over self by the self.  It is a crucial 
construct for successful human functioning, as it helps regulate one’s thoughts, 
emotions and behaviours in a stressful situation.  Self-regulation failure is reasoned 
to be the culprit behind substance abuse, criminal behaviour and obesity (Muraven & 
Baumeister, 2000).  Using Muraven and Baumeister’s limited strength model of self-
regulation as a framework, the present study was able to provide insight into one’s 
self-regulatory resources.  Specifically, participants’ psychological withdrawal 
symptoms increasing through their experience of concurrent stressors (i.e., 
temporary abstinence followed by depletion and cue-elicited smoking stimuli), 
provides indirect evidence that self-regulatory strength was likely being depleted.  
Unfortunately, the study design makes it impossible to distinguish the individual 
contribution that cognitive depletion vs. cue-elicited smoking stimuli made to 
increases in psychological withdrawal.  
 Future research is encouraged to further examine self-regulation and smoking 
abstinence.  For instance, does exercise replenish self-regulatory resources and if 
so, how does it do this?  Replenished self-regulatory resources counteract the 
negative effects of depletion by moderating tendencies to resort back to automatic 
behaviours (i.e., smoking) according to the limited strength model (Shmeuli & 
Prochaska, 2012).  Previous research has shown that positive affect induction 
through watching humorous video clips is able to replenish some self-regulatory 
strength in smokers who were not abstaining and postponed smoking behaviour 
(Shmeuli & Prochaska, 2012).  Moreover, research also suggests that exercise 
increases positive affect in smokers during temporary abstinence (Everson et al., 
2008).  Based on the evidence from the present study, it is possible that exercise 
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had a replenishing effect on psychological withdrawal (i.e., psychological withdrawal 
scores returned to baseline values) and through extension positively influenced 
strength of desire (cravings) scores.  While the primary focus of the present study 
was self-regulation depletion and not replenishment, a post-hoc analysis revealed 
that exercise did have a renewing effect on psychological withdrawal symptoms 
compared to passive controls.  It would be novel to explore the replenishing aspect 
of self-regulation through exercise in a population of smokers wishing to quit 
smoking.   
 Similarly, measurement of self-regulation should be further evaluated.  In 
previous research, self-regulation depletion and replenishment have been measured 
by task performance, for example improvement of grip strength, or on a Stroop task 
(Bray, Graham, Martin Ginis & Hicks, 2012).  Surrogates for self-regulation such as 
motivation and stress tolerance have also been suggested (Brown, Lejuez, Kahler, & 
Strong, 2002; Muraven & Slessareva, 2003).  Future research is needed to develop 
self-regulation measures that are less subjective and easier to quantify.  For 
instance, previous literature has suggested examining glucose use in the brain to 
determine the severity of depletion (Gailliot et al., 2007).  Moreover, fMRI could be 
employed to determine activation in certain areas of the brain to determine if an 
individual has been depleted (Janse Van Rensburg & Taylor, 2008).  
 
Effect of Exercise on Cravings  
This is the first time that exercise has been shown to decrease cravings 
following concurrent stressors compared to passive controls.  This finding is 
important as concurrent stressors represent a more ecologically valid setting since 
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stressors often occur simultaneously when an individual is attempting to quit 
smoking (e.g., stress from quitting smoking and daily life stressors).  Following 
concurrent stressors, participants who exercised at a moderate intensity 
experienced sustained, reduced cravings during their treatment, while passive 
control participants experienced sustained, heightened cravings.  The heightened 
and sustained cravings support that concurrent stressors had an impact on cigarette 
cravings.  This finding, again, speaks to the ecological validity of the study, as 
increased and sustained cigarette cravings eventually lead to smoking relapse 
during a serious quit attempt (Carter & Tiffany, 1999).       
Insofar as craving reduction is concerned, there was a 2.58 (46%) to 2.75 
(49%) reduction in strength of desire to smoke from concurrent stressor to during 
exercise treatment (i.e., 5, 10 and 15 minutes).  This is in line with other studies, 
which have reported 1.4 to 4.1-point reductions in strength of desire to smoke from 
pre-abstinence to during moderate intensity exercise (Taylor, Katomeri & Ussher, 
2005; Daniel et al., 2007; Everson et al., 2008; Janse Van Rensburg et al., 2012; 
Roberts et al., 2012).  The point reduction of exercise on strength of desire from 
concurrent stressor to immediately post treatment was 2.08 (37%), which again is in 
line with the research cited above.  The extremely large group by time interaction 
effect (η2 = .82) found indicates that exercise accounted for most of the decrease in 
cravings.  Overall these data provide strong evidence that exercise is a viable non-
pharmacological treatment for decreasing cravings in abstaining smokers. 
While the mechanisms behind this phenomenon are not clear, there are some 
explanations, which may shed light on the effect of exercise on cigarette cravings.  
First, research has suggested that changes in dopamine may mediate exercise and 
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affective responses (Acevedo & Ekkekakis, 2006).  An increase in dopamine activity, 
for example through exercise, has been shown to mediate the rewarding effects of 
drugs, including nicotine (Koob & Le Moal, 2001).  Future research is encouraged to 
examine changes in dopamine and other opioids, and cortisol both during and 
following exercise to further examine the relationship (Taylor & Katomeri, 2007).  
Second, changes in affective responses due to exercise may have 
ameliorated cravings in participants who exercised.  Negative affect is associated 
with increased desire to smoke (Shiffman & Waters, 2004).  Moreover, positive 
affect induction has been shown to decrease likelihood of smoking (Shmeuli and 
Prochaska, 2012).  Smokers who watched a humorous video clip were least likely to 
smoke compared to those who watched a neutral video clip.  Although affect was not 
measured during exercise in the current study, it is likely that exercise increased 
positive affect, which decreased cigarette cravings.  Research should examine the 
effect of exercise on cigarette cravings and affective responses following concurrent 
stressors.  
Third, shifts in attention and arousal have also been supported as possible 
explanations behind this phenomenon.  Janse Van Rensburg and colleagues (2012) 
suggest that a single bout of exercise may attenuate attentional shifts away from 
smoking-related cues.  fMRI scans showed no activation in the brain to smoking 
images compared to neutral images in participants who were temporarily abstaining 
from smoking and had exercised prior to scanning.  The authors suggest that the 
brain is overloaded with maintaining homeostasis during exercise (i.e., temperature 
regulation, heart rate regulation) that higher cognitive functioning (i.e., regulating 
emotions and behaviours in response to smoking cues and stressors) is temporarily 
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sacrificed.  However, this explanation warrants further research as it is still in its 
infancy. 
 
Effect of Exercise on Ad lib Smoking  
Delayed ad lib smoking may reduce the number of cigarettes smoked and 
harm inflicted on the smoker (deRuiter & Faulkner, 2006).  In addition, decreased 
cigarette consumption also decreases carcinogen exposure (USDHHS, 2010).  The 
current study found that exercise had no effect on ad lib smoking.  This finding is 
inconsistent with the current body of literature.  
For instance, Taylor & Katomeri (2007) examined the effects of exercise on 
ad lib smoking and found that those who exercised waited an average of 57 minutes 
before lighting up their next cigarette.  It is important to note that subjects abstained 
for 2-hours vs. 18 hours in the current study.  It is possible that an 18-hour 
abstinence period was too long for participants in the present study and a ceiling 
effect may have incurred for smoking outcomes (ad lib time).  Regardless of 
randomization, both groups may have been pushed to the limit and lit up a cigarette 
after leaving the laboratory.  Participants in the Taylor and Katomeri study were also 
younger [Mage = 27.1 (experimental) and Mage = 30.1 (control)] than the sample in the 
current study [(Mage = 35.7 (14.9) (moderate intensity exercise) and Mage = 39.1 
(15.2) (control)].  Based on age, it is likely that smokers in the current study had 
been smoking for a longer time [Mage = 17.8 years (moderate intensity exercise) and 
Mage = 21.2 years (control)] compared to those in Taylor and Katomeri study; and 
thus went back to smoking sooner due to force of habit (Conklin & Tiffany, 2002).   
  
45 
 
The correlations between ad lib time to first cigarette and strength of desire 
measured immediately post-treatment were stronger for participants who exercised 
at a moderate intensity (r = -.463, p = .178) than correlations reported by Taylor and 
Katomeri (2007) (r = -0.29, p < .05) even if they were not significant.  This suggests 
that while exercise did attenuate cravings during treatment, the residual effects from 
concurrent stressors may have been too difficult for participants to overcome without 
using smoking as a coping mechanism.   
Also, correlations between ad lib time and key demographic, smoking status, 
and psychological characteristics, and ad lib time and post-depletion psychological 
withdrawal symptoms were generally small and non-significant.  For instance, there 
was a small negative relationship found between ad lib smoking and post-depletion 
psychological withdrawal symptoms, suggesting that these constructs are mildly 
related.  This finding further strengthens the notion that those who are stressed will 
likely light up a cigarette sooner (Carter & Tiffany, 1999).  In addition, there was a 
small negative correlation between ad lib smoking and smoking ladder scores.  For 
individuals who are higher on the smoking ladder, perhaps entering the planning or 
action stages, it is possible that they would have waited before lighting their first 
cigarette.   
While the present study produced a null result for exercise on ad lib smoking, 
the finding that those who exercised showed a much larger correlation between 
cravings measured immediately post-treatment and ad lib smoking when compared 
to correlation found for the controls is encouraging.  It is therefore recommended 
that this study be replicated, perhaps with a shorter period of abstinence and a 
larger sample size to account for changes in ad lib smoking.  Moreover, 
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implementing technology such as ecological momentary assessment and smoking 
topography devices to measure changes in desire and smoking behaviour in real 
time and in natural surroundings would allow findings to be generalizable outside of 
a laboratory setting.  
 Interestingly, cravings measured post-treatment and psychological withdrawal 
symptoms measured post-depletion were not correlated.  This may seem like a 
contradiction; however, it should be noted that the time points from which the 
constructs are measured are not the same.  Cravings were measured at the end of 
treatment, where individuals had completed their respective conditions (moderate 
intensity exercise or passive sitting).  As mentioned previously, cravings had been 
attenuated for those who had exercised at a moderate intensity compared to those 
were in the passive condition.  Whereas, psychological withdrawal symptoms were 
measured when participants had been concurrently stressed (i.e., temporarily 
abstaining from cigarettes and depletion), but had yet to experience their respective 
conditions.  Due to the different time points and conditions of measurement, it seems 
appropriate that the constructs should not be correlated.  Conversely, if correlations 
were completed for the constructs at the same time points (i.e., post-depletion or 
post-treatment) higher correlations would be expected.   
Next, cravings were negatively, yet non-significantly, correlated with self-
control and coping self-efficacy (SE).  This relationship was expected as it is well 
documented that smokers use cigarettes as a coping mechanism (Taylor, 2000).  
However, psychological withdrawal symptoms were not related with self-control or 
coping SE.  This relationship was somewhat expected as psychological withdrawal 
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symptoms represent manifestations related to stress.  Stress is the antithesis to self-
control and coping SE and should therefore show little to no correlation.   
 An unexpected, significant negative relationship was found for FTCD scores 
and cigarettes smoked per day.  Smokers who smoke more per day are deemed 
less dependent on cigarettes.  One plausible explanation for this counterintuitive 
relationship is that the smokers in this study were not hardened smokers as reflected 
by their FTCD scores (three to four out of ten).  For instance, smokers were less 
likely to smoke upon waking and might not smoke while sick in bed.  Future research 
should further investigate all relationships using more statistically robust methods to 
give deeper insight on causation of relationships. 
 
Limitations 
 This study is not without limitations. For instance, findings can only be 
generalized to individuals who were able to temporarily abstain from smoking for 17 
– 18 hours.  Researchers did not examine the lasting effects of exercise on cravings 
post-treatment and this has been examined in previous studies (e.g., Ussher et al., 
2006).  Next, the study was conducted in a laboratory, under controlled conditions.  
Inferences drawn from the study cannot be applied to a more naturalistic setting.  
Also, the effects of the depletion task cannot be teased apart as it is unknown 
whether the Stroop task, or cue-elicited smoking stimulus contributed more to 
depleting participants.  In addition, the replenishing effects of exercise were not 
assessed.  Finally, this study relied on self-report measure for ad lib smoking.  
Researchers were unable to validate the accuracy of reporting. 
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Conclusions 
Overall, this is the first study to examine the effect of a single bout of 
moderate intensity exercise on cigarette cravings in smokers who had been 
concurrently stressed by temporary abstinence and cognitive depletion/ cue-elicited 
smoking stimuli.  This study represents a more ecologically valid lab-based scenario 
than previous research.  Findings from this study support exercise as an effective 
strategy for ameliorating strength of desire to smoke.  The effect of exercise on ad 
lib smoking cannot be supported by the present study.  Future work is now needed 
where momentary assessment is used in participants’ natural environment to 
examine changes over time in cigarette cravings following acute bouts of exercise. 
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   Recruitment Advertisement 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Smoking Research Study 
The Exercise and Health Psychology Lab is 
looking for male and female adult smokers to 
participate in a short term quit smoking study. 
Compensation is available.  
To be eligible you must: 
• Be between 18-64 years of age 
• Smoke at least 10 cigarettes per day for 
the past 2 years 
• Not have another substance dependency 
problem, or mental or physical disorder(s) 
• For females only, not be pregnant or 
considering becoming pregnant 
 
If interested please contact Angela. 
 
Smoking Participants Needed! 
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Letter of Information – Control Participants 
 
LETTER OF INFORMATION 
 
Study Title: The effect of exercise on cravings, withdrawal and ad libitum 
smoking following concurrent stressors. 
 
Principal Study Investigator:  
Harry Prapavessis, Ph.D. (School of Kinesiology, The University of Western Ontario) 
 
Co-Investigator: 
Angela Fong, B.A. (School of Kinesiology, The University of Western Ontario) 
 
Stefanie De Jesus, PhD. Candidate (School of Kinesiology, The University of 
Western Ontario) 
 
You are being invited to participate in a research study looking at the effects of a 
short period of exercise on smoking behavior. This is a randomized control trial (a 
type of research study), which includes eligible volunteers who choose to take part. 
Please take your time to make a decision, and discuss this proposal with your 
personal doctor, family members and friends, as you feel inclined. The purpose of 
this letter is to provide you with the information you require to make an informed 
decision on participating in this research. This letter contains information to help you 
decide whether or not to participate in this research study. It is important for you to 
know why the study is being conducted and what it will involve. Please take the time 
to read this carefully and feel free to ask questions if anything is unclear or there are 
words or phrases you do not understand. We are asking you to take part because 
you are an adult between 18 and 64 years of age who smokes. 
 
Purpose of the study 
Exercise has been shown to help with traditional quit smoking strategies. A single 
bout of low to moderate intensity exercise can help regulate cravings and withdrawal 
symptoms.  
 
The primary objective of this study is to examine the effects of an acute bout of 
moderate intensity exercise on smoking cravings and withdrawal symptoms 
following a psychological stress test (i.e. word-colour interference test) during a 
period of smoking abstinence. The second purpose of this study is to assess the 
effect of an exercise bout on smoking behaviour after concurrent stressors. 
 
Participants 
Forty participants will be asked to take part in this research. To be eligible to 
participate, you must meet the following criteria: 18 and 64 years of age, smoke 10 
or more cigarettes per day for more than 2 years, have not engaged in a serious quit 
attempt in the last six months, must not be suffering from an illness (e.g. cold) that 
would affect your typical smoking behavior, do not have a medical condition that 
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prevents you from exercising, not be pregnant or intending on becoming pregnant. 
You must also be able to read and write in English and provide a telephone or e-mail 
account to the investigators so that the investigators can contact you. 
 
Research Procedure 
If you choose to take part in this study, you will be asked to complete three study 
components:  
A) first laboratory session, B) temporarily abstain from smoking, C) second 
laboratory session.  
The laboratory sessions will be held at the Exercise and Health Psychology 
Laboratory (EHPL) at Western University. The EHPL is located in Room 408 of the 
Labatt Health Sciences Building.  Each laboratory session will take approximately 60 
minutes. 
 
A) First laboratory session 
During your first laboratory session, you will complete a questionnaire package (see 
Item 1) and the following information will be collected: weight, height, breath carbon 
monoxide levels (see Item 3) and saliva samples (see Item 4) for nicotine 
metabolism analysis. You will also complete a computerized time reaction test to 
measure your executive function (see Item 1a). Executive function is an ability that 
allows you to select a response or make a decision.We are looking at an executive 
function called inhibition, which is your ability to stop unwanted actions and 
unwanted responding. One example of inhibition in your everyday life is, when you 
think something but then stop yourself from saying your thoughts. You are inhibiting 
(or stopping) your thoughts from being verbalized.At the end of your first laboratory 
session, we will schedule your second laboratory session within seven days of your 
first laboratory session.It is within your rights to refuse to answer any questionnaire 
items and we will honour your rights. You will receive half your compensation at this 
time. 
 
B) Abstain from smoking 
You will be asked to abstain from smoking for at least 18 hours prior to your 
laboratory visit (see Item 7).  We will confirm that you have not smoked in the last 18 
hours by asking you to complete a carbon monoxide test (Item 3).  
 
C) Second laboratory session 
During your secondlaboratory session, smoking abstinence will be confirmed by 
breath carbon monoxide levels (Item 3).  If the carbon monoxide value shows that 
you are not smoke-free at this time, we will reschedule your appointment.If at that 
time you again are unable to abstain, you will be ineligible to continue with the study.  
After, you will complete a psychological stress test (see Item 5).  After the test, you 
will complete a questionnaire package that addresses cigarette cravings, withdrawal 
symptoms and coping items (Item 6).  Upon completing the questionnaire package, 
you will you will be asked to sit passively for 15 minutes.  During this time, you will 
be asked to complete the cigarette craving questionnaire at 5 and 10 minutes (found 
in Items 1, 2 and 6).Following sitting, you will be asked to fill out the cigarette 
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cravings and withdrawal symptoms questionnaires again.  It is within your rights to 
refuse to answer any questionnaire items and we will honour your rights.  
 
Upon completion of the cigarette cravings and withdrawal symptoms questionnaire 
package, you will be asked to report the time of your first cigarette after you leave 
the lab by phone (leaving a message on a secure line) or email.  You will be given a 
reminder slip that contains our contact information (telephone number and email 
address).  The remainder of your compensation will be given to you at this time. 
 
 
Experimental description (items 1-8) 
 
Item 1: Pre-screening questionnaire package (first lab visit) 
Time Involvement: 20 minutes 
The questionnaire package will include: PAR-Q, coping questionnaire, cigarette 
cravings questionnaire and withdrawal symptoms questionnaire.   
 
Item 1a: Computerized Time Reaction Test  
Time Involvement: 20 minutes 
We will measure your reaction time on a button press computer task. Reaction time 
is the time it takes you to respond (press a key on keyboard) to a prompt (flash) on 
the computer screen. 
 
Item 2: Baseline questionnaire package (second lab visit) 
Time Involvement: 30 minutes 
The questionnaire package will include: demographics information sheet, smoking 
history questionnaire, seven-day physical activity recall questionnaire, nicotine 
dependence questionnaire, coping questionnaire, cigarette cravings questionnaire 
and withdrawal symptoms questionnaire.  
 
Item 3: Carbon monoxide assessments 
Time Involvement: 15 seconds  
We will ask you to breathe into a machine called the Bedfont Smokerlyzer. This 
machine measures the amount of carbon monoxide (CO) as you breathe out. It does 
not cause any harm or discomfort to you. This Smokerlyzer measures how much 
you have smoked in the past several hours. A CO value of less than 6 parts per 
million will confirm that you have temporarily stopped smoking. 
 
Item 4: Provide saliva sample on cotton swab 
Time Involvement: 2 minutes 
From this saliva sample we will measure the 3-hyrdroxycotinine and cotinine within 
your body to determine a 3-hyrdroxycotinine/cotinine ratio.  This ratio tells us about 
the rate at which your body metabolizes (breaks down) nicotine. 
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Item 5: Psychological stress test 
Time Involvement: 2 minutes and 45 seconds.  
You will be asked to complete a psychological test called the Stroop task.  This task 
involves colour words (e.g./ red, green, blue and yellow) presented in mismatched 
ink colours (e.g./ the word blue might be printed in green ink).  You will be asked to 
say aloud the colour that the word is printed in and not the actual word itself.  For 
example, if the word blue is presented in green ink you would say “green.”  Some 
words will be presented in red ink, for these words you must say the actual word 
itself and not the colour of the printed ink.  For example if the word yellow is 
presented in red ink you would say “yellow.”  These words will be presented to you 
on a computer screen.   
 
Item 6: Post-test questionnaire package 
Time Involvement: 15 minutes 
The questionnaire package will include: coping questionnaire, self-control 
questionnaire, cigarette cravings questionnaire and withdrawal symptoms 
questionnaire.   
 
Item 7: Abstain from smoking for 18-24 hours 
We ask that prior to your second laboratory session you abstain from smoking for at 
least 18 hours (18-24hours).  
 
Item 8: Ad libitum smoking behavior 
When you have completed the laboratory session, you will be asked to report the 
time of your first cigarette after you leave the EHPL.  You be provided with a 
reminder slip that will contain two different ways you can contact us (phone, or 
email).  If you forget to contact us, we will call or email you as a reminder. 
 
Risks 
While in the study, you may experience side effects.  Known side effects are listed 
below, but other effects may occur that we cannot predict.  If you are or become 
pregnant you must notify the investigator as smoking involves risks to the foetus. 
 
Temporary Smoking Abstinence: You may experience withdrawal symptoms during 
the time you are abstaining from cigarettes. Such symptoms may include feeling 
edgy and nervous, dizzy, sweaty, having trouble concentrating, headaches, 
insomnia, increased appetite and weight gain, muscular pain, constipation, fatigue, 
or having an upset stomach. All of these symptoms are common for those who have 
temporarilyquit smoking so you should not be alarmed, as these symptoms will go 
away within a few days. Moderate intensity exercise has been shown to reduce 
smoking withdrawal symptoms, so it could be that those in the moderate intensity 
exercise treatment condition experience relief from some of these symptoms. 
Another common side effect of temporarily quitting smoking is that your “smoker’s 
cough” gets worse for the first few days after you temporary quit. This is your body’s 
way of attempting to rid the lungs of excess toxins. Your smoker’s cough will 
improve largely if you have become smoke-free for a number of days.  
 
  
 
70 
Benefits 
Your participation may help you and us get knowledge to shape the development of 
future exercise and smoking cessation programs.  
 
Participation 
Participation in this study is voluntary.  You may refuse to participate, refuse to 
answer any questions or withdraw from the study at any time with no effect on your 
academic or employment status. If you decide to take part you will be given this 
Letter of Information to keep and be asked to sign the consent form. If you withdraw 
from the study, you maintain the right to request that any data collected from you not 
be used in the study. If you make such a request, all of the data collected from you 
will be destroyed. Please contact the study coordinator, Angela Fong, if you wish to 
withdraw from the study. If you are participating in another study at this time, please 
inform the study researchers right away to determine if it is appropriate for you to 
participate in this study. 
 
Biological Specimens 
The sample we are asking of you during the course of this study is saliva.  This 
saliva sample will be used for the current study only. The saliva sample will be 
frozen in our laboratory freezer, then shipped and analyzed at the University of 
Toronto in Canada for an indication of how quickly you metabolize (break down) 
nicotine in your body (3-hydroxycotinine: cotinine ratio). Bar codes will be used to 
label your saliva samples, so the laboratory technicians analyzing your saliva will 
have no information as to who provided the saliva sample. The samples will be 
stored for a minimum of 3 years. Usage and potential research value will be 
reviewed annually thereafter. It is typical to keep the samples collected from a 
research study for 6 years after the study has been conducted. Once the research 
value is deemed lower than sufficient to justify storage costs, the samples will be 
destroyed by standard disposal of biohazardous waste laboratory policies and 
procedures.  If we would like to use your saliva for a different study or for a different 
purpose in this study, we will send you a new letter of information and ask your 
permission. 
 
Any specimen(s) obtained for the purposes of this study will become the property of 
the study researchers and once you have provided the specimens you will not have 
access to them. The specimen(s) will be discarded or destroyed once they have 
been used for the purposes described in the protocol. The specimen(s) will be used 
for research and such use may result in inventions or discoveries that could become 
the basis for new products or diagnostic or therapeutic agents. In some instances, 
these inventions and discoveries may be of potential commercial value and may be 
patented and licensed by the researcher. It is not the purpose of this study to use 
specimens for any inventions or patents, so it is very unlikely that this will occur as 
an outcome of a sample you provide us with. You will not receive any money or 
other benefits derived from any commercial or other products that may be developed 
from use of the specimens. 
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New Findings 
If, during the course of this study, new information becomes available that may 
relate to your willingness to continue to participate, this information will be provided 
to you by the investigator (for instance, if a new quit-smoking aid becomes 
available). 
 
Confidentiality 
We will be collecting information from 40 participants for this study.  All the 
information you provide to the researcher will be kept in the strictest confidence.  
You will be assigned an identification number and all data collected from you will be 
recorded and stored under this number only. All data will be stored in coded form on 
computers accessible only to research staff in a secure office. You will not be 
identified in any documents relating to the research. No information obtained during 
the study will be discussed with anyone outside of the research team. If the results 
of the study are published, your name will not be used.  
 
Representatives of the University of Western Ontario Health Sciences Research 
Ethics Board and regulatory bodies (Health Canada) may contact you or require 
access to your study-related records to monitor the conduct of the research. If we 
find information we are required by law to disclose, we cannot guarantee 
confidentiality. We will strive to ensure the confidentiality of your research- related 
records. Absolute confidentiality cannot be guaranteed, as we may have to disclose 
certain information under certain laws.  
 
Compensation 
Free parking will be provided for your visits to the laboratory.  If public transportation 
is required for participation in this study you will be reimbursed to a maximum of 
$15.00 (half distributed at the first lab visit and the remainder given out at the second 
lab visit). 
 
If you have private medical or life insurance, you should check with your insurance 
company before you agree to take part in the study to confirm your participation in 
this study will not affect your insurance coverage and/or access to benefits. 
 
This study is covered by Western University’s insurance policy and if during the 
course of the study, any injury should occur to you, not due to your fault or 
negligence, all medical expenses necessary to treat such injury will be paid 
provided: a) you comply at all times with the study researcher’s instructions b) you 
promptly report any such injury to the study researchers conducting the study, and c) 
the expenses are not otherwise covered by your provincial health care. Financial 
compensation for such things as lost wages, disability or discomfort due to this type 
of injury is not routinely available.You do not waive any legal rights by signing the 
consent form. 
 
Alternative treatments 
If you decide not to participate or if you withdraw from the study before it is 
completed, the alternative course of treatment could be to see your family physician 
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for advice on how to quit smoking.  Another alternative to the procedures described 
above is not to participate in the study and continue on just as you do now. 
 
Contact person(s) 
If you have any questions about your rights as a research participant or the conduct 
of the study you may contact Dr. David Hill, Scientific Director, Lawson Health 
Research Institute.  If you have any questions about the study, please contact the 
study coordinator, Angela Fong, or Stefanie De Jesus, or Dr. Harry Prapavessis. 
 
This letter is for you to keep.  You will be given a copy of this letter of information 
and consent form once it has been signed. If you have any concerns, please feel 
free to contact one of the researchers below.  You may request the general findings 
of this research study from the researchers after the study is complete.  You do not 
waive any legal rights by singing the consent form. 
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INFORMED CONSENT 
 
Study Title: The effect of exercise on cravings, withdrawal and ad libitum 
smoking following concurrent stressors. 
 
I have read the Letter of Information, have had the nature of the study explained to 
me and I agree to participate.  All questions have been answered to my satisfaction. 
 
Please send me the overall conclusions from this trial:    Yes □ No □ 
 
I consent for my study related data to be used in future research studies:       
Yes □ No □ 
 
I would like to be contacted for other research studies:     Yes □ No 
□ 
 
Consenting Signature: 
 
Participant: ________________________________________________________     
       Please Print Name 
 
 
Participant: ________________________________________________________     
       Please Sign Name 
 
Date:  ___________________ 
 
 
 
 
 
Researcher Signature: 
 
Person obtaining informed consent:     
 
_______________________________________          
   Please Print Name 
 
 
Person obtaining informed consent:     
 
_______________________________________       
                                  Please Sign Name 
 
Date: _________________
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Letter of Information – Experimental Participants 
 
LETTER OF INFORMATION 
 
Study Title: The effect of exercise on cravings, withdrawal and ad libitum 
smoking following concurrent stressors. 
 
Principal Study Investigator:  
Harry Prapavessis, Ph.D. (School of Kinesiology, The University of Western Ontario) 
 
Co-Investigators: 
Angela Fong, B.A. (School of Kinesiology, The University of Western Ontario) 
 
Stefanie De Jesus, PhD. Candidate (School of Kinesiology, The University of 
Western Ontario) 
 
You are being invited to participate in a research study looking at the effects of a 
short period of exercise on smoking behavior. This is a randomized control trial (a 
type of research study), which includes eligible volunteers who choose to take part. 
Please take your time to make a decision, and discuss this proposal with your 
personal doctor, family members and friends, as you feel inclined. The purpose of 
this letter is to provide you with the information you require to make an informed 
decision on participating in this research. This letter contains information to help you 
decide whether or not to participate in this research study. It is important for you to 
know why the study is being conducted and what it will involve. Please take the time 
to read this carefully and feel free to ask questions if anything is unclear or there are 
words or phrases you do not understand. We are asking you to take part because 
you are an adult between 18 and 64 years of age who smokes. 
 
Purpose of the study 
Exercise has been shown to help with traditional quit smoking strategies. A single 
bout of exercise, low to moderate in intensity, can help regulate cravings and 
withdrawal symptoms.  
 
The primary objective of this study is to examine the effects of an acute bout of 
moderate intensity exercise on smoking cravings and withdrawal symptoms after 
concurrent stressors (i.e., temporary abstinence and a psychological test) following a 
period of smoking abstinence. The second purpose of this study is to assess the 
effect of exercise on smoking behaviour after concurrent stressors. 
 
Participants 
Forty participants will be asked to take part in this research. To be eligible to 
participate, you must meet the following criteria: 18 and 64 years of age, smoke 10 
or more cigarettes per day for more than 2 years, have not been engaged in a 
serious quit attempt in the last six months, must not be suffering from an illness (e.g. 
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cold) that would affect your typical smoking behavior, do not have a medical 
condition that prevents you from exercising, not be pregnant or intending on 
becoming pregnant.  You must also be able to read and write in English and have a 
telephone or e-mail account that the investigators can contact you at. 
 
Research Procedure 
If you choose to take part in this study, you will be asked to complete three study 
components:  
A) first laboratory session, B) abstain from smoking, C) secondlaboratory session.  
The laboratory sessions will be held at the Exercise and Health Psychology 
Laboratory (EHPL) at Western University. The EHPL is located in Room 408 of the 
Labatt Health Sciences Building.  Each laboratory session will take approximately 60 
minutes. 
 
A) First laboratory session 
During your first laboratory session, you will complete a questionnaire package (see 
Item 1) and the following information will be collected: weight, height, breath carbon 
monoxide levels (see Item 3) and saliva samples (see Item 4) for nicotine 
metabolism analysis. You will also complete a computerized time reaction test to 
measure your executive function (see Item 1a). Executive function is an ability that 
allows you to select a response or make a decision. We are looking at an executive 
function called inhibition, which is your ability to stop unwanted actions and 
unwanted responding. One example of inhibition in your everyday life is, when you 
think something but then stop yourself from saying your thoughts. You are inhibiting 
(or stopping) your thoughts from being verbalized.At the end of your first laboratory 
session, we will schedule your second laboratory session within seven days of your 
first laboratory session. It is within your rights to refuse to answer any questionnaire 
items and we will honour your rights. You will receive half your compensation at this 
time. 
 
B) Abstain from smoking 
You will be asked to abstain from smoking for at least 18 hours prior to your 
laboratory visit (see Item 7).  We will confirm that you have not smoked in the last 18 
hours by asking you to complete a carbon monoxide test (see Item 3).  
 
C) Second laboratory session 
During your second laboratory session, smoking abstinence will be confirmed by 
breath carbon monoxide levels (Item 3).  If the carbon monoxide value shows that 
you are not smoke-free at this time, we will reschedule your appointment.  If at that 
time you again are unable to abstain, you will be ineligible to continue with the study.  
After, you will complete a psychological test (see Item 5).  After the test, you will 
complete a questionnaire package asking questions about cigarette cravings, 
withdrawal symptoms and coping (see Item 6).  Upon completing the questionnaire 
package, you will you will be asked to exercise at a moderate intensity on a treadmill 
for 15 minutes.  Approximately 5 minutes into exercising, you will complete the 
cravings questionnaire, only (found in Items 1, 2 and 6).  You will be asked complete 
the cravings questionnaire again after 10 minutes and 15 minutes of exercising.  The 
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questions will be asked to you verbally and you will look at a copy of the scale on 
laminated card.  You will give your answer verbally to the exercise supervisor.  In 
addition, you will be asked how hard you are working every 2 minutes.  A rate of 
perceived exertion scale will be presented to you on a laminated card.  Again, you 
will give your answer verbally.  
 
When 15 minutes has passed, you be asked to fill out a questionnaire package 
asking about cigarette cravings and withdrawal symptoms.  It is within your rights to 
refuse to answer any questionnaire items and we will honour your rights.  Upon 
completion of the cigarette cravings and withdrawal symptoms questionnaire 
package, you will be asked to report the time of your first cigarette after you leave 
the lab by phone (leaving a message on a secure line)or email.  You will be given a 
reminder slip that contains our contact information (telephone number and email 
address).  The remainder of your compensation will be given to you at this time. 
 
Experimental description (items 1-8) 
 
Item 1: Pre-screening questionnaire package (first lab visit) 
Time Involvement: 20 minutes 
The questionnaire package will include: PAR-Q, coping questionnaire, cigarette 
cravings questionnaire and withdrawal symptoms questionnaire.   
 
Item 1a: Computerized Time Reaction Test  
Time Involvement: 20 minutes 
We will measure your reaction time on a button press computer task. Reaction time 
is the time it takes you to respond (press a key on keyboard) to a prompt (flash) on 
the computer screen. 
 
Item 2: Baseline questionnaire package (second lab visit) 
Time Involvement: 30 minutes 
The questionnaire package will include: demographics information sheet, smoking 
history questionnaire, seven-day physical activity recall questionnaire, nicotine 
dependence questionnaire, coping questionnaire, cigarette cravings questionnaire 
and withdrawal symptoms questionnaire.  
 
Item 3: Carbon monoxide assessments 
Time Involvement: 15 seconds  
We will ask you to breathe into a machine called the Bedfont Smokerlyzer. This 
machine measures the amount of carbon monoxide (CO) as you breathe out. It does 
not cause any harm or discomfort to you. This Smokerlyzer measures how much 
you have smoked in the past several hours. A CO value of less than 6 parts per 
million will confirm that you have temporarily stopped smoking. 
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Item 4: Provide saliva sample on cotton swab 
Time Involvement: 2 minutes 
From this saliva sample we will measure the 3-hyrdroxycotinine and cotinine within 
your body to determine a 3-hyrdroxycotinine/cotinine ratio.  This ratio tells us about 
the rate at which your body metabolizes (breaks down) nicotine. 
 
Item 5: Psychological stress test 
Time Involvement: 2 minutes and 45 seconds.  
You will be asked to complete a psychological test called the Stroop task.  This task 
involves colour words (e.g./ red, green, blue and yellow) presented in mismatched 
ink colours (e.g./ the word blue might be printed in green ink).  You will be asked to 
say aloud the colour that the word is printed in and not the actual word itself.  For 
example, if the word blue is presented in green ink you would say “green.”  Some 
words will be presented in red ink, for these words you must say the actual word 
itself and not the colour of the printed ink.  For example if the word yellow is 
presented in red ink you would say “yellow.”  These words will be presented to you 
on a computer screen.   
 
Item 6: Post-test questionnaire package 
Time Involvement: 15 minutes 
The questionnaire package will include: coping questionnaire, self-control 
questionnaire, cigarette cravings questionnaire and withdrawal symptoms 
questionnaire.   
 
Item 7: Abstain from smoking for 18-24 hours 
We ask that prior to your second laboratory session you abstain from smoking for at 
least 18 hours (18-24hours).  
 
Item 8: Ad libitum smoking behavior 
When you have completed the laboratory session, you will be asked to report the 
time of your first cigarette after you leave the EHPL.  You be provided with a 
reminder slip that will contain two different ways you can contact us (phone, or 
email).  If you forget to contact us, we will call or email you as a reminder. 
 
Risks 
While in the study, you may experience side effects.  Known side effects are listed 
below, but other effects may occur that we cannot predict.  If you are or become 
pregnant you must notify the investigator as smoking involves risks to the foetus. 
 
Exercise: There are some inherent risks of injury associated with exercise 
participation, particularly among people who are not used to exercising. You may, for 
example, feel mild muscle “tightness” or soreness that lasts for a couple of days.  
The possible benefits associated with exercise may outweigh the potential minor 
discomfort of beginning a supervised, laboratory-based exercise program.  To 
minimize the physical risks of exercise, proper warm-up/cool-down and stretching 
protocols will be performed by a trained exercise counsellor.  Additionally, the 
exercise program delivered will be tailored to your individual fitness level, and 
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modified according to your comfort level.  Furthermore, you will only be allowed to 
participate in this exercise program if you complete the PAR-Q (Physical Activity 
Readiness Questionnaire) forms to ensure that it is safe for you to begin an exercise 
program.  The exercise facilitator will be both CPR and First Aid trained, and 
experienced in working with previously inactive populations.If any physical or mental 
risks arise during treatment, The Student Emergency Response Team (SERT) will 
be available to provide immediate assistance. SERT will assist the exercise 
supervisor until the 911 emergency services arrive.  Should you have a minor injury, 
for instance sore knees, or cramped muscles (e.g./ a “Charlie horse”), while 
exercising you will receive first aid onsite as required.  A first aid kit and ice packs 
will be available for minor injuries. 
 
Temporary Smoking Abstinence: You may experience withdrawal symptoms during 
the time you are abstaining from cigarettes. Such symptoms may include feeling 
edgy and nervous, dizzy, sweaty, having trouble concentrating, headaches, 
insomnia, increased appetite and weight gain, muscular pain, constipation, fatigue, 
or having an upset stomach. All of these symptoms are common for those who have 
temporarily quit smoking so you should not be alarmed, as these symptoms will go 
away within a few days. Moderate intensity exercise has been shown to reduce 
smoking withdrawal symptoms, so it could be that those in the moderate intensity 
exercise treatment condition experience relief from some of these symptoms. 
Another common side effect of temporarily quitting smoking is that your “smoker’s 
cough” gets worse for the first few days after you temporary quit. This is your body’s 
way of attempting to rid the lungs of excess toxins. Your smoker’s cough will 
improve largely if you have become smoke-free for a number of days.  
 
Benefits 
Your participation may help you and us gain knowledge to shape the development of 
future exercise and smoking cessation programs.  
 
Participation 
Participation in this study is voluntary.  You may refuse to participate, refuse to 
answer any questions or withdraw from the study at any time with no effect on your 
academic or employment status. If you decide to take part you will be given this 
Letter of Information to keep and be asked to sign the consent form. If you withdraw 
from the study, you maintain the right to request that any data collected from you not 
be used in the study. If you make such a request, all of the data collected from you 
will be destroyed. Please contact the study coordinator, Angela Fong, if you wish to 
withdraw from the study. If you are participating in another study at this time, please 
inform the study researchers right away to determine if it is appropriate for you to 
participate in this study.  
 
Biological Specimens 
The sample we are asking of you during the course of this study is saliva.  This 
saliva sample will be used for the current study only. The saliva sample will be 
frozen in our laboratory freezer, then shipped and analyzed at the University of 
Toronto in Canada for an indication of how quickly you metabolize (break down) 
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nicotine in your body (3-hydroxycotinine: cotinine ratio). Bar codes will be used to 
label your saliva samples, so the laboratory technicians analyzing your saliva will 
have no information as to who provided the saliva sample. The samples will be 
stored for a minimum of 3 years. Usage and potential research value will be 
reviewed annually thereafter. It is typical to keep the samples collected from a 
research study for 6 years after the study has been conducted. Once the research 
value is deemed lower than sufficient to justify storage costs, the samples will be 
destroyed by standard disposal of biohazardous waste laboratory policies and 
procedures.  If we would like to use your saliva for a different study or for a different 
purpose in this study, we will send you a new letter of information and ask your 
permission. 
 
Any specimen(s) obtained for the purposes of this study will become the property of 
the study researchers and once you have provided the specimens you will not have 
access to them. The specimen(s) will be discarded or destroyed once they have 
been used for the purposes described in the protocol. The specimen(s) will be used 
for research and such use may result in inventions or discoveries that could become 
the basis for new products or diagnostic or therapeutic agents. In some instances, 
these inventions and discoveries may be of potential commercial value and may be 
patented and licensed by the researcher. It is not the purpose of this study to use 
specimens for any inventions or patents, so it is very unlikely that this will occur as 
an outcome of a sample you provide us with. You will not receive any money or 
other benefits derived from any commercial or other products that may be developed 
from use of the specimens. 
 
New Findings 
If, during the course of this study, new information becomes available that may 
relate to your willingness to continue to participate, this information will be provided 
to you by the investigator (for instance, if a new quit-smoking aid becomes 
available). 
 
Confidentiality 
We will be collecting information from 40 participants for this study.  All the 
information you provide to the researcher will be kept in the strictest confidence.  
You will be assigned an identification number and all data collected from you will be 
recorded and stored under this number only. All data will be stored in coded form on 
computers accessible only to research staff in a secure office. You will not be 
identified in any documents relating to the research. No information obtained during 
the study will be discussed with anyone outside of the research team. If the results 
of the study are published, your name will not be used.  
 
Representatives of the University of Western Ontario Health Sciences Research 
Ethics Board and regulatory bodies (Health Canada) may contact you or require 
access to your study-related records to monitor the conduct of the research. If we 
find information we are required by law to disclose, we cannot guarantee 
confidentiality. We will strive to ensure the confidentiality of your research- related 
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records. Absolute confidentiality cannot be guaranteed, as we may have to disclose 
certain information under certain laws.  
 
Compensation 
Free parking will be provided for your visits to the laboratory.  If public transportation 
is required for participation in this study you will be reimbursed to a maximum of 
$15.00(half distributed at the first lab visit and the remainder given out at the second 
lab visit). 
 
If you have private medical or life insurance, you should check with your insurance 
company before you agree to take part in the study to confirm your participation in 
this study will not affect your insurance coverage and/or access to benefits. 
 
This study is covered by Western University’s insurance policy and if during the 
course of the study, any injury should occur to you, not due to your fault or 
negligence, all medical expenses necessary to treat such injury will be paid 
provided: a) you comply at all times with the study researcher’s instructions b) you 
promptly report any such injury to the study researchers conducting the study, and c) 
the expenses are not otherwise covered by your provincial health care. Financial 
compensation for such things as lost wages, disability or discomfort due to this type 
of injury is not routinely available. You do not waive any legal rights by signing the 
consent form. 
 
Alternative treatments 
If you decide not to participate or if you withdraw from the study before it is 
completed, the alternative course of treatment could be to see your family physician 
for advice on how to quit smoking.  Another alternative to the procedures described 
above is not to participate in the study and continue on just as you do now. 
 
Contact person(s) 
If you have any questions about your rights as a research participant or the conduct 
of the study you may contact Dr. David Hill, Scientific Director, Lawson Health 
Research Institute.  If you have any questions about the study, please, Angela Fong, 
or Stefanie De Jesus, or Dr. Harry Prapavessis. 
 
This letter is for you to keep.  You will be given a copy of this letter of information 
and consent form once it has been signed. If you have any concerns, please feel 
free to contact one of the researchers below.  You may request the general findings 
of this research study from the researchers after the study is complete.  You do not 
waive any legal rights by singing the consent form. 
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INFORMED CONSENT 
 
Study Title: The effect of exercise on cravings, withdrawal and ad libitum 
smoking following concurrent stressors. 
 
I have read the Letter of Information, have had the nature of the study explained to 
me and I agree to participate.  All questions have been answered to my satisfaction. 
 
Please send me the overall conclusions from this trial:    Yes □ No □ 
 
I consent for my study related data to be used in future research studies:       
Yes □ No □ 
 
I would like to be contacted for other research studies:     Yes □ No 
□ 
 
Consenting Signature: 
 
Participant: ________________________________________________________     
       Please Print Name 
 
 
Participant: ________________________________________________________     
       Please Sign Name 
 
Date:  ___________________ 
 
 
 
 
 
Researcher Signature: 
 
Person obtaining informed consent:   
 
_______________________________________          
   Please Print Name 
 
 
Person obtaining informed consent:     
 
_______________________________________       
                                Please Sign Name 
 
Date: ___________________ 
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Ad lib Smoking Reminder Slip 
 
REMINDER!! 
 
Thank you for participating in this temporary quit smoking study. Please remember 
to email or leave a message with the following information: 
 
  ID#    and TIME of first cigarette 
 
Please remember to be as accurate as you can with the time and do not leave your 
name so that your information remains confidential. Thank you! 
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Debriefing Letter 
 
 
 
 
 
REMINDER AND DEBRIEFING LETTER 
 
Study Title: The effect of exercise on cravings, withdrawal and ad libitum 
smoking following concurrent stressors. 
 
Principal Study Investigator:  
Harry Prapavessis, Ph.D. (School of Kinesiology, The University of Western Ontario) 
 
 
Co-Investigator: 
Angela Fong, B.A. (School of Kinesiology, The University of Western Ontario) 
 
 
Stefanie De Jesus, PhD. Candidate (School of Kinesiology, The University of 
Western Ontario) 
 
Thank you for participating in my study.  
 
Before you completed the Stroop task (word-colour association or “intelligence” test), 
you were told that this test is a reflection of your intelligence, but that was a trick to 
stress you out. Also, you were told that for every error on your Stroop task you would 
look $1.00 of your compensation, but that was a trick to stress you out even more. 
You have received your full compensation ($15.00 total) and this test was not a 
reflection of your intelligence. This task is designed to demand your attention to 
make you mentally tired. 
 
Please remember to email or call with the time and date of your first cigarette after 
leaving the laboratory. Please remember to only leave your identification number (3-
digit number) and the time and date of your cigarette. For confidentiality purposes do 
not leave your name.     
 
If you have any questions about the study, please contact the study coordinator, 
Angela Fong, or Stefanie De Jesus, or Dr. Harry Prapavessis  
 
Angela Fong 
Graduate Student 
School of Kinesiology, 
Western University 
 
Stefanie De Jesus 
Graduate Student 
School of Kinesiology, 
Western University 
 
Dr. Harry Prapavessis 
Professor 
School of Kinesiology, 
Western University 
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Appendix B 
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Shiffman – Jarvik Withdrawal Scale – Psychological Symptoms Subscale 
 
 
INSTRUCTIONS: Please CIRCLE the number to the right of each question that most 
accurately reflects how you feel at this moment. 
 
 Definitely 
Do Not Feel 
 Definitely                   
Feel 
1. Do you feel more calm than usual? 1 2 3 4 5 6 7 
2. Are you able to concentrate as well as usual? 1 2 3 4 5 6 7 
3. Do you feel content? 1 2 3 4 5 6 7 
4. Do you feel more tense than usual? 1 2 3 4 5 6 7 
5. Are you feeling irritable? 1 2 3 4 5 6 7 
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Cravings 
 
INSTRUCTIONS: Please CIRCLE the number on the line below for each question 
that most accurately reflects how you feel at this moment. 
 
 
1. How strong is your desire to smoke right now? 
 
 
Not at all  Somewhat   Extremely 
1 2 3 4 5 6 7 
87 
Demographic Questionnaire 
 
 
First Name:_______________________  Last Name:_____________________         
 
Address:_____________________________________________________________________ 
                          STREET ADDRESS, CITY, POSTAL CODE 
 
Home Phone: ________- _________-_________ 
 
Email Address: 
__________________________________________@_____________________ 
 
Date of Birth: ________/________/___________               Age: _________ 
 
Gender:  Male     Female  
 
Height: __________   Weight: ___________  BMI: ____________ 
 
 
SMOKING STATUS AND HISTORY 
 
Please indicate the length of time you have smoked: ________________________ 
 
On average, how many cigarettes do you smoke per day? : ___________________ 
 
Do you currently smoke any other substance besides cigarettes?    Yes   No 
 
If yes, please specify (e.g. marijuana, cigar, pipe, cigarello, waterpipe tobacco/hookah): 
 
______________________________________________________________________ 
 
Have you ever smoked any other substance besides cigarettes?    Yes   No 
 
If yes, please specify (e.g. marijuana, cigar, pipe, cigarello, waterpipe tobacco/hookah): 
 
______________________________________________________________________ 
 
Does anyone in your household currently smoke?   Yes   No 
 
Do you drink Alcohol?  Yes   No 
 
If yes, number of drinks per week? _____________ 
 
What is the approximate date and time of the last cigarette you have smoked? 
    
Date:  ______________ Time: _______________ 
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Physical Activity Readiness Questionnaire (PARQ) 
 
1. Has your doctor ever said that you have a heart condition and that you should only 
do physical activity recommended by a doctor? 
a. [   ] Yes 
b. [   ] No 
 
2. Do you feel pain in your chest when you do physical activity? 
a. [   ] Yes 
b. [   ] No 
 
3. In the past month, have you had chest pain when you were not doing physical 
activity? 
a. [   ] Yes 
b. [   ] No 
 
4. Do you lose your balance because of dizziness or do you ever lose consciousness? 
a. [   ] Yes 
b. [   ] No 
 
5. Do you have a bone or joint problem that could be made worse by a change in your 
physical activity? 
a. [   ] Yes 
b. [   ] No 
 
6. Is your doctor currently prescribing drugs (for example, water pills) for your blood 
pressure or heart? 
a. [   ] Yes 
b. [   ] No 
 
7. Do you know of any other reason why you should not do physical activity? 
a. [   ] Yes 
b. [   ] No 
 
___________________________________  
Name 
 
       
Signature 
 
       
Date 
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7-Day Physical Activity Recall Questionnaire 
INSTRUCTIONS: Please complete the chart below with information regarding any work, 
household or leisure activities that are at a level of intensity that makes you breathe 
slightly harder than normal, makes your heart beat faster than normal and lasts for at 
least 5 minutes. We’d like to know about any of this type of physical activity, which you 
have done in the last week, starting with yesterday and working backward. 
 
Moderate activity is activity, which feels similar to a brisk walk. 
Hard activity is activity, which feels harder than a brisk walk. 
Very hard activity is activity, which feels similar to running or jogging.  
 
1. Please complete the following chart with specific activities that you’ve done this week. 
DAY MORNING AFTERNOON EVENING Minutes of  
Activity 
1 (yesterday) 
 
    
2 
 
    
3 
 
    
4 
 
    
5 
 
    
6 
 
    
7 
 
    
W: Walk, Exh: Sructured home exercise, Exf: Structured exercise facility, H: 
Housework,  
Sw: Swimming, DIY: Do it yourself, Cyc: Cycling, G: Gardening, D: Dancing,  
Spi: Sport/individual, Spt: Sport Team ,  Occ: Occupational, O: Other (please state).  
 
2. Number of minutes spent last week doing moderate activity:    . 
3. Number of minutes spent last week doing hard activity:     . 
4. Number of minutes spent last week doing very hard activity:    . 
5. Number of days with 30 minutes or more of hard or very hard activity:  
 . 
6. Number of days with 30 minutes or more of moderate, hard or very hard activity:   
7. How much physical activity did you do last week compared to the previous 3 months?  
(Circle one box only) 
Much less Less About the same More Much more 
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Fagerstrom Test for Cigarette Dependency 
1. How many cigarettes per day do you usually smoke? (Circle the number that 
best represents your cigarette consumption) 
 
a. 10 or less 
 
b. 11 to 20 
 
c. 21 to 30 
 
d. 31 or more 
 
2. How soon after you wake up do you smoke your first cigarette? (Circle one 
response) 
 
a. Within 5 minutes 
 
b. 6 to 30 minutes 
 
c. 31 or more 
 
3. Do you find it difficult to refrain from smoking in places where it is forbidden (e.g. 
in church, at the library, in the cinema)? (Circle one response) 
 
a. No 
 
b. Yes 
 
4. Which cigarette would you most hate to give up? (Circle one response) 
 
a. The first of the morning 
 
b. Other 
 
5. Do you smoke more frequently in the first hours after waking than during the rest 
of the day? (Circle one) 
 
a. No 
 
b. Yes 
 
6. Do you smoke if you are so ill that you are in bed most of the day? (Circle one 
response) 
a. No 
 
b. Yes 
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Smoking Ladder Questionnaire 
 
Below are some thoughts that smokers have about quitting. On this ladder, circle the 
one number that shows what you think about quitting. Please read each sentence 
carefully before deciding. 
 
 
10 I have quit smoking and I will never smoke again. 
9 I have quit smoking, but I still worry about slipping back, so I need to keep 
working on living smoke free. 
8 I still smoke, but I have begun to change, like cutting back on the number of 
cigarettes I smoke. I am ready to set a quit date. 
7 I definitely plan to quit smoking with the next 30 days. 
6 I definitely plan to quit smoking in the next 6 months. 
5 I often think about quitting smoking, but I have no plans to quit. 
4 I sometimes think about quitting smoking, but I have no plans to quit. 
3 I rarely think about quitting smoking, and I have no plans to quit. 
2 I never think about quitting smoking, and I have no plans to quit. 
1 I enjoy smoking and have decided not to quit smoking for my lifetime. I have 
no interest in quitting. 
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Brief Self-Control Questionnaire 
 
INSTRUCTIONS: Using the scale provided, please indicate how much each of the 
following statements reflects how you typically are. 
 
1.  I am good at resisting temptation. 
         
Not at 
all    
Very 
much 
1 2 3 4 5 
 
2.  I have a hard time breaking bad habits.  
       
Not at 
all 
   Very 
much 
1 2 3 4 5 
 
3.  I am lazy.   
           
Not at 
all    
Very 
much 
1 2 3 4 5 
 
4.  I say inappropriate things.  
         
Not at 
all    
Very 
much 
1 2 3 4 5 
 
5.  I do certain things that are bad for me, if they are fun.   
    
Not at 
all    
Very 
much 
1 2 3 4 5 
 
6.  I refuse things that are bad for me.  
         
Not at 
all    
Very 
much 
1 2 3 4 5 
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7.  I wish I had more self-discipline. 
         
Not at 
all    
Very 
much 
1 2 3 4 5 
 
8.  People would say that I have iron self-discipline.      
  
Not at 
all 
   Very 
much 
1 2 3 4 5 
 
9.  Pleasure and fun sometimes keep me from getting work done.   
    
Not at 
all    
Very 
much 
1 2 3 4 5 
 
10.  I have trouble concentrating.    
       
Not at 
all    
Very 
much 
1 2 3 4 5 
 
11.  I am able to work effectively toward long-term goals.  
     
Not at 
all    
Very 
much 
1 2 3 4 5 
 
12.  Sometimes I can’t stop myself from doing something, even if I know it is wrong. 
    
Not at 
all    
Very 
much 
1 2 3 4 5 
      
13.  I often act without thinking through all the alternatives.       
 
Not at 
all    
Very 
much 
1 2 3 4 5 
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Coping Self-Efficacy Questionnaire 
INSTRUCTIONS: Using the scale below write a number from 0 to 10 for the following 
items.  
 
 
When things aren't going well for you, or when you're having problems, how confident or 
certain are you that you can do the following: 
 
1. Make unpleasant thoughts go away.       
2. Take your mind off unpleasant thoughts.       
3. Stop yourself from being upset by unpleasant thoughts.    
4. Keep from feeling sad.         
5. Keep from getting down in the dumps.       
6. Look for something good in a negative situation.     
7. Keep yourself from feeling lonely.        
8. Visualize a pleasant activity or place.       
9. Pray or meditate.          
 
 
 
 
 
 
Coping Self-Efficacy Scale v. 06-08-10 
 
1 
 
When things aren't going well for you, or when you're having problems, how confident or certain are you 
that you can do the following: 
 
 Cannot Moderately Certain 
 do at certain can 
 all can do do 
 
 0 1 2 3 4 5 6 7 8 9 10 
 
 
For each of the following items, write a number from 0 - 10, using the scale above. 
 
When things aren't going well for you, how confident are you that you can: 
 
1. Keep from getting down in the dumps.   99 
 
2. Talk positively to yourself.   99 
 
3. Sort out what can be changed, and what can not be changed.   99 
 
4. Get emotional support from friends and family.   99 
 
5. Find solutions to your most difficult problems.   99 
 
  
 
6. Break an upsetting problem down into smaller parts.   99 
 
7. Leave options open when things get stressful.   99 
 
8. Make a plan of action and follow it when confronted with a problem.   99 
 
9. Develop new hobbies or recreations.   99 
 
10. Take your mind off unpleasant thoughts.   99 
 
  
 
11. Look for something good in a negative situation.   99 
 
12. Keep from feeling sad.   99 
 
13. See things from the other person's point of view during a heated argument.   99 
 
14. Try other solutions to your problems if your first solutions don’t work.   99 
 
15. Stop yourself from being upset by unpleasant thoughts.   99 
 
please go on to next page  Â 
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Curriculum Vitae for Angela J. Fong 
 
 
ACADEMIC HISTORY 
 
Masters of Arts, Kinesiology – Exercise Psychology            2012 – 2013  
University of Western Ontario, London, ON, Canada 
 
Bachelors of Arts, Kinesiology                 2006 –2010 
University of Western Ontario, London, ON, Canada 
 
 
RESEARCH EXPERIENCE  
 
 
Research Assistant – Exercise at Western    May 2013 – Aug 2013 
Dr. C. R. Hall, The University of Western Ontario, London, ON 
Dr. W. Rodgers, Dr. T. Berry, University of Alberta, Edmonton, AB 
 
Research Assistant – Go Girls! Research Project               Dec 2012 – May 2013 
A. Justine Wilson (PhD. candidate) and Dr. M. R. Beauchamp, University of British 
Columbia, Vancouver, BC 
 
 
Physical Activity Coordinator (PAC) – CO.21 Trials         May 2012 – Present 
Dr. K. S. Courneya, University of Alberta, Edmonton, AB 
 
 
Research Coordinator – Getting Physical on Cigarettes Trial   Sept 2010 – Present 
Dr. H. Prapavessis, The University of Western Ontario, London, ON 
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